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Abstract 
 
Camel milk has been used for its nutritional and therapeutic benefits since ancient 
times. Previously, whole camel milk and casein proteins have been explored for their 
potential bioactive properties. However, studies on camel milk whey proteins and their 
hydrolysates are still scarce. Hence, the aim of the proposed thesis was to evaluate 
camel whey proteins and their hydrolysates for potential bioactivities like antioxidant, 
antimicrobial, antidiabetic, antihypertensive, and anti-cholesterol properties. 
Production of the hydrolysates was carried out using three digestive enzymes – pepsin, 
trypsin and chymotrypsin for 3 and 6 h of hydrolysis time. Hydrolysates were 
characterized by degree of hydrolysis (DH) and reversed-phase high-performance 
liquid chromatography (RP-HPLC). In vitro experiments were performed to evaluate 
the bioactive properties of different camel whey protein hydrolysates (CWPHs). 
Results revealed that CWPHs showed DH ranging from 11 to 47.5%, with 
chymotrypsin (6 h) and trypsin (3 h) exhibiting highest and lowest DH, respectively. 
RP-HPLC analysis revealed that α-lactalbumin underwent complete degradation and 
newer shorter peptides were generated. Chymotrypsin generated CWPHs 
demonstrated highest 2,2-diphenyl-1-picrylhydrazy (DPPH) and 2,2'-azino-bis (3-
ethylbenzothiazoline-6-sulphonic acid) (ABTS) radical scavenging activities, while 
trypsin generated CWPHs displayed highest metal chelating activity. CWPHs showed 
markedly greater antimicrobial activity than unhydrolyzed whey against all pathogenic 
bacteria tested. Anti-cholesterol property via inhibition of cholesterol esterase and 
lipase, and antihypertensive property via angiotensin-converting enzyme (ACE) 
inhibition were found to be highest in pepsin (6 h) and (3 h) generated CWPHs, 
respectively. CWPHs also displayed potential antidiabetic activity compared to intact 
whey proteins, where pepsin and chymotrypsin generated CWPHs showed higher 
inhibition of dipeptidyl peptidase-IV (DPP-IV), α-glucosidase and α-amylase (P < 
0.05). Overall, CWPHs exhibited improved antioxidant, antimicrobial, and 
antidiabetic properties as well as ACE, cholesterol esterase, and lipase inhibitory 
effects compared to intact whey proteins in the in vitro conditions. Therefore, CWPHs 
could be targeted for utilization as bioactive ingredient in functional foods and 
nutraceuticals. 
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 )cibarA ni( tcartsbA dna eltiT
 
وصف الخصائص البيولوجية لمتحللات بروتينات مصل حليب النوق التي انتجت من 
 معاملة بروتينات المعدة والامعاء الدقيقة
 
 صالملخ
تم استخدام حليب الإبل لفوائده الغذائية والعلاجية منذ العصور القديمة. في السابق، تم 
الحيوية النشطة. ومع ذلك، لا استكشاف حليب الإبل الكامل وبروتينات الكازيين لخصائصهما 
تزال الدراسات حول بروتينات مصل اللبن في حليب الإبل وتحللاتها نادرة. ومن هنا، كان الهدف 
من الرسالة المقترحة هو تقييم بروتينات مصل حليب النوق وتحللاتها المائية من أجل نشاطاتها 
ومضادات السكر، وخافضات الحيوية المحتملة كمضادات الأكسدة، ومضادات الميكروبات، 
ضغط الدم، وخواص ازالة الكولسترول. تم إجراء إنتاج متحللات البروتين من بروتينات مصل 
 6و  3البيبسين ، التريبسين والكيميوتريبسين لمدة  -حليب النوق باستخدام ثلاثة إنزيمات هضمية 
ماتوغرافيا السائلة عالية الأداء والكرو )HD( المتحللات البروتينية بدرجة التحلل ساعات. تم تقييم
وأجريت التجارب المختبرية لتقييم الخصائص البيولوجية لمتحللات البروتين  .)CLPH-PR(
تتراوح من  مصل الحليب النوق المختلفة. أظهرت بروتينات مصل حليب النوق ان نسب التحلل
والتي تظهر أعلى  ساعات) 3ساعات) والتربسين ( 6الكيميوتريبسين ( ٪ ، مع 5.74إلى  11
والكروماتوغرافيا السائلة عالية الأداء أن  وأدنى نسبة تحلل بروتيني، على التوالي. كشف تحليل
لاكتوالبومين خضع لعملية تحلل كاملة وأُنتجت ببتيدات أقصر. متحللات البروتين -بروتين الفا
للأكسدة، في  ) كمضاداتSTBA) و (HPPDأظهر أعلى ( التي تولد من فعل الكيموتريبسين
أعلى من مضاد الاكسدة.  حين متحللات البروتين الناتجة من معاملة انزيم التربسين انتجت معدل
متحللات البروتين نشاط مضاد للميكروبات أكبر بشكل ملحوظ من مصل اللبن غير  وأظهرت
 معامل ضد جميع البكتيريا المسببة للأمراض التي تم اختبارها. 
 
: حليب الإبل، بروتين مصل اللبن، التحلل، مضاد للضغط، استريز سيةمفاهيم البحث الرئي
 الكوليسترول
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Chapter 1: Introduction 
 
1.1 Overview 
Camel milk, in its fresh or fermented form, is considered an important part of 
staple diet in many parts of the world, particularly in the arid and semi-arid zones (El-
Agamy, 2007). Camels are categorized into two species: Camelus dromedarius (one-
humped camel) and Camelus bactrianus (two-humped camel). The one-humped 
camels live in the hot, arid regions in Africa, Middle-East and Africa, while the two-
humped camels are mostly found in cold and arid areas of China, Kazakhstan, and 
Mongolia (El-Agamy, 2007). Traditionally, camel milk has been used for treatment of 
diseases like tuberculosis, asthma, dropsy, and jaundice (Abdelgadir et al., 1998). 
Also, camel milk is said to have better digestibility and nutritional value than bovine 
milk, making it one of the alternatives sources for human consumption (Salami et al., 
2009). There are some important differences between camel and bovine milk proteins. 
For instance, camel milk lacks β-lactoglobulin (β-LG), a major protein in bovine milk 
that can trigger allergic reactions. Moreover, camel whey protein has higher contents 
of antimicrobial agents than bovine whey like lactoferrin, lysozyme, immunoglobulin, 
and lactoperoxidase (Ahamad et al., 2017).  These differences in proteins of camel 
milk might display variable biological activities upon hydrolysis. Camel whey proteins 
with different biological activities such as mineral-binding properties and 
immunoglobulins have been reported (Farah & Atkins, 1992; Merin et al., 2001).  
Peptides from dietary proteins have been extensively studied to investigate the 
health effects they may show in humans like antioxidant activity, mineral binding, 
reduction in blood pressure, immunomodulatory function and protective effects 
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against various bacteria and viruses (Salami et al., 2010). Such peptides from milk 
proteins are widely acknowledged (Kitts & Weiler, 2003). Indigenous protease 
enzymes like milk plasmin, can hydrolyze proteins and liberate bioactive peptide 
fragments during storage or processing (Mohanty et al., 2016). Bioactive peptides can 
also be obtained via enzymatic hydrolysis with microbial and digestive enzymes 
(Korhonen & Pihlanto, 2003). The activity of peptides is based on their inherent amino 
acid composition and sequence (Meisel & Fitzgerald, 2003). Because camel milk has 
different protein and amino acid profiles, it may be a good source of bioactive peptides 
that might display variable biological activities (Khalesi et al., 2017)  
The health-related bioactive properties of camel milk protein hydrolysates have 
recently been reported (Salami et al., 2010, 2011; Kumar et al., 2016a, 2016b; 
Nongonierma et al., 2017b, 2018). These hydrolysates were obtained via enzymatic 
hydrolysis of camel milk proteins, which are susceptible to proteolysis (Salami et al., 
2011). Enzymatic hydrolysis is known to improve the functional properties of milk 
proteins in addition to enhancement of the bioactive properties (Jrad, 2014). However, 
camel milk proteins in their intact form have demonstrated bioactive properties like 
anti-cancer, anti-hypertensive, hypo-allergic, and anti-diabetic (Konuspayeva et al., 
2009).  Most of these properties of intact camel milk proteins have been demonstrated 
in the in-vivo (human or rat model) systems. Since enzymatic hydrolysis can enhance 
the bioactive properties of milk proteins, recent research is being focused on 
generating bioactive hydrolysates from camel milk proteins and exploring their 
potential bioactive properties in the in vitro as well as in vivo conditions (Mudgil et 
al., 2018).  
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1.2 Statement of the Problem 
In the UAE, camel milk production has increased to 42,400 tonnes, following 
the growth in camel heads from 219713 to 412000 over the past decade (Mirzaei, 
2012). The augmentation is not just limited to increase in camel milk production, but 
several research attempts have been carried out, focusing on the health benefits of the 
whole camel milk itself. Peptides derived from the milk of goat, sheep, and buffalo 
exert multifunctional properties, including anti-microbial, immune modulatory, anti-
oxidant, inhibitory effect on enzymes, anti-thrombotic, and antagonistic activities 
against various toxic agents (Konuspayeva et al., 2009). During recent years, major 
bovine whey protein components, α-LA and β-LG, have also been shown to contain 
bioactive peptide sequences. Peptides showing opioid and angiotensin-converting 
enzyme (ACE) inhibitory activity were found in bovine α-LA and β-LG (Solieri et al., 
2015). With diverse and extensive reports on milk derived bioactive peptides, research 
focus is intensively being paid on the exploration of newer source of milk bioactive 
peptides. In the recent years, the research activities on camel milk protein hydrolysates 
has started taking pace. Considerable amount of work has been reported recently on 
whole camel milk protein hydrolysate, however, studies exploring camel whey 
proteins and their hydrolysates are still deficient. Camel whey protein hydrolysates 
were previously demonstrated to possess antioxidant and antimicrobial properties 
(Salami et al., 2010). To the best of our knowledge, there is no study being conducted 
on investigating the antidiabetic properties (DPP-IV, α-amylase, α-glucosidase), lipase 
and cholesterol esterase inhibiting properties of camel whey protein hydrolysates. 
Also, data available on in-depth exploration of antioxidant and antimicrobial 
properties of camel whey protein hydrolysates is limited. Thus, the present study has 
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three main objectives – (i) to produce protein hydrolysates from camel milk whey 
using different enzymes, and time of hydrolysis, (ii) to characterize the whey protein 
hydrolysate using degree of hydrolysis and reversed-phase high performance liquid 
chromatography (RP-HPLC), and (iii) to evaluate the whey protein hydrolysates 
for various bioactivities including antioxidant, antimicrobial, antihypertensive, 
antidiabetic and anti-cholesterol effects. The findings of this study can be exploited in 
the development of foods with special health claims (e.g. treatment of hypertension, 
diabetes, etc.) as well as in identifying new applications for camel milk derived 
bioactive peptides. 
5 
 
 
 
 
Chapter 2: Relevant Literature 
 
Milk is a commodity consumed by millions of people around the world. Its 
nutritional benefits are several, one of which is the growth and development of bones 
in young children, due to milk being a good source of calcium and vitamin D. It has 
also proven to be beneficial for older people, especially in menopausal women where 
calcium deficiency is a high-risk factor for the development of osteoporosis. Milk is 
not only a source of nutrition, but its production also contributes to food security and 
income for most people in the developing countries. Around 150 million households 
are engaged in milk production across the globe (FAO, 2012). It is particularly 
beneficial for small scale producers because of quick cash turnouts. 
 One of the non-bovine sources which provides the required human nutrition 
and offers therapeutic benefits is camel milk (Bai & Zhao, 2015). Camel milk yield 
varies with breed, species, feeding conditions, and stage of lactation (Khaskheli et al., 
2005). Camel milk is white opaque, with a slightly salty taste. The pH of camel milk 
ranges from 6.2 to 6.5 which is lower than that of bovine milk (6.5 to 6.7) (El-Hatmi 
et al., 2015). The fat content in camel milk is very low, having 96% triglycerides 
(Ereifej et al., 2011) and about 30 mg/100 g dry matter of cholesterol (Salwa & Lina, 
2010). Camel milk’s fat has less short chain fatty acids in comparison to bovine milk 
(Ereifej et al., 2011). Furthermore, the fat globules’ average size is smaller compared 
to bovine, buffalo, and goat milk fat globules (Khalesi et al., 2017). Although these 
differences may be why camel milk is highly digestible (Meena et al., 2014), it can 
cause problem in technological applications (Khalesi et al., 2017). Camel milk is rich 
in vitamins including B1, B2 and vitamin C (Ereifej et al., 2011). Particularly, vitamin 
C in camel milk is almost three to five times higher than bovine milk, which makes 
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camel milk an important part of diet, especially in arid areas where green foods have 
limited accessibility (Zhao et al., 2015; Kamal & Karoui, 2017) 
2.1 Protein Composition in Camel Milk 
 Protein content in the camel milk has been reported to vary with respect to 
breed and season. For example, protein content was found to be highest in December 
(2.9%) and lowest in August (2.48%) in the study reported by Haddadin et al. (2008). 
Camel milk contains two major protein types; caseins and whey proteins. The camel 
whey protein is not only composed of numerous soluble proteins, but also indigenous 
proteases present in camel milk such as chymotrypsin A and cathepsin D (Alhaider et 
al., 2013). Thus, the camel milk proteins themselves may be bioactive or could serve 
as precursors for bioactive peptides.  
2.1.1 Casein Proteins 
 Casein is the major protein in camel milk, which constitutes 52-87% of total 
protein content (Khaskheli et al., 2005). Casein is composed of three main 
components: αs1- casein, αs2-casein, and β-casein, and a fourth minor fraction -
casein. The major camel milk casein is β-casein (65% of total casein), which is higher 
than the β-casein in bovine milk (36%). Similar to human milk, camel milk contains a 
high percentage of β-casein that might reflect in its higher digestibility rate than bovine 
milk: β-casein is more sensitive to pepsin hydrolysis than αS1-casein (El-Agamy et 
al., 2009). On the other hand, camel milk has lower αs1-casein (21%), in comparison 
to bovine αs1-CN (38%). The high percentage of β–casein in camel milk gives it a 
higher digestibility rate and lower incidence of allergy in the gut of infants, as β-casein 
is more easily hydrolyzed than αs-casein (El-Agamy et al., 2009). It has been reported 
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that camel milk caseins have higher molecular masses in contrast to bovine caseins, 
such that β-casein and α-casein were 28.6 kDa and 35 kDa respectively in camel milk, 
while in bovine it was 24 kDa for β-casein, and 22-25 kDa for α-casein (Farah, 1986). 
The -casein in camel milk is only 3.47% of total casein, whereas bovine milk 
has 13% of –casein. Studies have shown that -casein is relatively harder to detect 
because of its low concentrations in the camel milk (Farah & Atkins, 1992). The 
hydrolysis sites for -casein in both camel and bovine milk differ; chymosin 
hydrolyzes -casein at the Phe97-Ile98 bond in camel milk, while bovine –casein is 
hydrolyzed at the Phe105-Met106 bond (Kappeler et al., 1998). Furthermore, it has been 
observed that there is an additional proline residue in -casein, which plays a critical 
role in the stability of camel milk (Kappeler et al., 1998). 
Recently, the concentration of each casein component, except αS2-casein, was 
determined in camel milk by capillary electrophoresis; it consisted of approximately 
12.8 mg/mL of β-casein, 2.9 mg/mL of αS1-casein, and 1.7 mg/mL of -casein (Omar 
et al., 2016). 
2.1.2 Whey Proteins 
 In camel milk, whey constitutes about 30% of the total proteins (Zhao et al., 
2015) and are mainly composed of α-lactalbumin (α-LA), lactophorin, 
immunoglobulins (Ig), lactoferrin (Lf), and serum albumin (Ochirkhuyag et al., 1998; 
Merin et al., 2001; El-Hatmi et al., 2006). Immunoglobulin G (IgG) is the dominant 
immunoglobulin present in camel milk and the molecular weights of camel Ig differ 
to those of bovine, sheep, goat and human (Alavi et al., 2018).  α-LA and β –
lactoglobulin (β-LG) are the major difference between bovine and camel whey, such 
8 
 
 
 
 
that camel whey lacks β–LG, which is the main component in bovine whey (50%) (El-
Agamy et al., 2009). β–LG induces heat stability; hence the stability of camel milk is 
poor at temperatures up to 140 ºC in contrast to bovine milk (Farah & Atkins, 1992; 
Al-Saleh, 1996). α-LA is the major component of camel whey, while bovine whey has 
only 25% of this protein (Farah, 1986; Farah & Atkins, 1992; Merin et al., 2001; 
Laleye et al., 2008).  
The molecular mass of α-LA in camel milk is reported to be 14.6 kDa with 123 
residues, which is similar to bovine, goat and human milk (Beg et al., 1985, 1986). 
However, the amino acid sequence of camel milk α-LA differs largely from that of 
bovine, goat, and other species (Al Haj & Al Kanhal, 2010). Both camel and human 
milk are known to contain high contents of α-LA and lactoferrin (Lf) (Hinz et al., 
2012). Lack of β-lactoglobulin, one of the major allergenic whey proteins in bovine 
milk, makes camel milk a good substitute, with a potential to be used in infant formula. 
The bioactive peptides which could be generated from camel whey proteins might 
differ from bovine whey and other sources of whey proteins with respect to bioactive 
properties.  
Among the beneficial properties of camel milk, its anti-microbial activity is 
mainly attributed to the high content of protective proteins in the whey fraction. Whey 
proteins such as Lf, IgGs, lactoperoxidase, lysozyme, and other enzymes are potent 
antimicrobial components in camel milk (El-Agamy et al., 1992; Konuspayeva et al., 
2005). All these anti-microbial constituents (except camel lactoperoxidase for which 
no data are available) are present in significantly higher concentration in camel milk 
compared to bovine milk and are known to be more thermostable (El-Agamy et al., 
2009). Therefore, camel whey proteins present a novel source of proteins which can 
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generate bioactive peptides with potential health benefits. 
2.2 Functional Properties of Camel Milk Proteins 
 Whey proteins have unique characteristics (Parodi, 2007). Apart from their 
great importance in nutrition, they exhibit chemical, physical, physiological, 
functional, and technological features useful in food application (McIntosh et al., 
1998). Based on these properties, more and more individual protein isolates and 
protein concentrates of whey have been incorporated in food at industrial scale. 
Therefore, whey proteins address two major issues in practice: nutritionally, they 
supply energy and essential amino acids, and functionally, they help in modification 
of texture, structure and overall appearance of food – e.g. gel formation, foam stability 
and water retention. 
Few studies have investigated the denaturation of camel whey proteins and its 
effect on emulsifying, foaming, protein films and gel forming properties (Panyam & 
Kilara, 1996). Technological properties such as thermal stability during drying, heat 
induced aggregation, fouling properties and thin consistency have been explored in 
fermented camel milk (Merin et al., 2001; El-Agamy, 2007; El-Hatmi et al., 2007; 
Laleye et al., 2008).  A recent study by Al Shamsi et al. (2018) produced camel milk 
protein hydrolysates using proteolytic enzymes – alcalase, bromelain and papain. The 
techno-functional properties like emulsifying activity index, surface hydrophobicity, 
and protein solubility were investigated. It was found that these properties were higher 
in the protein hydrolysates compared to unhydrolyzed camel milk proteins. Also, their 
antioxidant potential was assessed in real food and in vitro systems. Thus, the potential 
application of camel milk protein hydrolysates as a functional food ingredient due to 
their enhanced techno-functional properties could be a novel approach.  
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2.3 Milk Protein Hydrolysates, Bioactive Peptides and Their Production 
 Past research findings have proven proteins to be a good source of essential 
amino acids. In addition, more recent research has been emerging which documents 
other functionalities and bioactive properties of milk proteins demonstrated by 
biologically active peptides. These peptides remain in an inactive state within the 
parent protein molecule and demonstrate bioactive potential only when released from 
the native protein (Khalesi et al., 2017).  
Bioactive peptides are defined as those peptides that consist of specific protein 
fragments which show biological activity and may be beneficial in promoting health 
(Kitts & Weiler, 2003). The hydrolysis (or breakdown) of proteins to get these peptides 
can be from various sources, but at present, milk derived peptides are the most 
important source (Korhonen, 2009). Many studies have reviewed the production and 
properties of peptides from milk proteins (Clare & Swaisgood, 2000; Korhonen & 
Pihlanto, 2003; Pihlanto & Korhonen, 2003; Meisel, 2005; Silva & Malcata, 2005; 
Korhonen & Pihlanto, 2006). Several bioactive peptides seem to have beneficial health 
effects on digestive, cardiovascular, immune and nervous systems (Hernández-
Ledesma et al., 2011; Korhonen & Pihlanto, 2006). The active sequences may be from 
2 to 20 amino acids long (Korhonen, 2009). 
Biologically active peptides can be produced from milk proteins in three 
different ways: 1) enzymatic hydrolysis (using digestive or microorganisms and plant 
derived enzymes), 2) fermentation (using proteolytic starter cultures), and 3) heating 
under alkali/acid conditions (Pihlanto-Leppälä, 2000; Muro Urista et al., 2011). 
Sometimes, a combination of the above methods also helps in obtaining highly potent 
peptide fractions with diverse bioactive properties (Korhonen, 2009).  
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2.3.1 In Vitro Enzymatic Hydrolysis 
Controlled enzymatic hydrolysis is critical in producing hydrolysates for three 
reasons: (i) to preserve the properties of generated products, peptides and amino acids 
(Tavano, 2013), (ii) to avoid excessive protein hydrolysis that can (a) result in bitter 
flavored peptides (Jung et al., 2005) and (b) hinder functionality, and (iii) to maintain 
the improved solubility in the protein as a result of the hydrolysis process (Tavano, 
2013). Thus, by controlling the degree of hydrolysis, one may be able to obtain and 
explain the potential bioactive and/or functional properties of the protein hydrolysates. 
 In this process, whole protein molecule undergoes hydrolysis (or breakdown) 
by enzymes like pepsin, trypsin, and chymotrypsin. These enzymes can mimic 
gastrointestinal digestion effects on the food peptides (Tavano, 2013). Other 
proteolytic enzymes such as alcalase, subtilisin, and thermolysin are used in 
conjunction with pepsin and trypsin to generate peptides with known biological 
activities (Agyei & Danquah, 2011). Liberation of peptides with a wide range of 
actions can thus be achieved using different enzymes (Tavano, 2013). The bioactivity 
of peptides has been extensively reported in literature, although the mechanism of 
actions is not well understood. Few studies hypothesize it as a structure-activity 
relationship, while others suggest that the enzyme can be chosen to get the desired 
fragment and effect (Tavano, 2013).   
The milk protein hydrolysates can be produced from different casein or whey 
proteins (Meisel & FitzGerald, 2003; Yamamoto et al., 2003; FitzGerald et al., 2004; 
Gobbetti et al., 2004). Casein hydrolysates have been reported to produce good ACE-
inhibitory peptides (Otte et al., 2007), while whey peptides with sequence Ile-Leu-Pro-
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Met-His-Ile-Arg from 𝛽-LG have also been identified to have strong antihypertensive 
activity (Mullally et al., 1997; Maes et al., 2004).   
2.4 Bioactive Properties of Whey Protein Hydrolysates 
 Whey is a good source of nutrients and important peptides. To concentrate 
whey proteins and obtain nutritional value, several technologies like heating, drying, 
reverse osmosis, and membrane separation have been applied. Another approach is 
hydrolysis of whey to produce hydrolysates containing bioactive peptides. These 
peptides can be released by enzymatic hydrolysis in vitro as discussed previously. 
Thereafter, bioactive peptides from whey protein can act on major organ systems of 
the body and impart physiological functions to these systems (Sharma, 2014). Milk 
protein hydrolysates are known to possess various bioactive properties as discussed 
below. 
2.4.1 Antioxidant Activity  
 Oxidation of food is a major concern in food spoilage. Lipid oxidation not 
only deteriorates the food quality, but also shortens the shelf life and generates free 
radicals that can in turn cause decomposition of fatty acids, which may decrease the 
safety and nutritional value of the food. Thus, it is critical to hinder lipid oxidation 
process and formation of free radicals (Peng et al., 2009). Synthetic antioxidants have 
been incorporated into food products and prove to be cost-effective and efficient, but 
their potential toxic effects to human health have led manufacturers to seek natural 
antioxidants (Ito et al., 1985).  
Enzymatic hydrolysis of milk proteins, particularly those from bovine has been 
widely explored for generation of bioactive peptides with potential antioxidant 
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properties. For example, antioxidant peptides from bovine αs-casein showed 
properties like free-radical scavenging and inhibition of enzymatic and non-enzymatic 
lipid peroxidation (Rival et al., 2001). Hydrolysis of bovine whey proteins have also 
resulted in peptides that may have antioxidant activity (Zhang et al., 2013).  
The principle mechanism behind antioxidant activity of peptides is not very 
well understood, but studies have shown that they are free radical scavengers 
(Rajapakse et al., 2005; Moure et al., 2006; Qian et al., 2008), metal ions chelators 
(Rajapakse et al., 2005) and inhibitors of lipid peroxidation (Wu et al., 2003; Moure 
et al., 2006; Qian et al., 2008). Antioxidant properties of the peptides are influenced 
by their structure, composition, hydrophobicity, and peptide sequence (Chen et al., 
1998; Rajapakse et al., 2005). Other factors affecting antioxidant activity of bioactive 
peptides include degree of hydrolysis, type of protease (Peñta-Ramos et al., 2002; 
Gibbs et al., 2004), peptide structure (Saito et al., 2003), and peptide concentration 
(Chen et al., 2007). Some recent studies have started exploring camel milk as a 
potential protein substrate for generating bioactive protein hydrolysates with 
antioxidant activities (Al-Saleh et al., 2014; Shori, 2014) which are summarized in 
Table 1. Other studies like those of Jrad et al. (2014a) and Salami et al. (2011) have 
reported higher antioxidant activity of camel milk casein hydrolysates when digested 
with gastrointestinal enzymes.    
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Table 1: Antioxidant activity of bioactive protein hydrolysates obtained from camel 
milk or colostrum proteins 
Protein source In vitro test Results Reference 
𝛼-LA from camel 
whey 
ABTS Greater antioxidant activity 
compared to bovine 𝛼-LA 
Salami et al. (2009) 
Camel colostrum, 
colostral whey 
protein 
ABTS Radical scavenging activity 
increased following 
enzymatic digestion 
Jrad et al. (2014b) 
Whey protein + its 
hydrolysates 
ABTS Higher antioxidant activity 
compared to bovine whey 
protein and their 
hydrolysates 
Salami et al. (2010) 
Fermented camel 
milk peptide 
fractions (casein) 
ABTS More pronounced 
scavenging activity than 
bovine milk 
Moslehishad et al. 
(2013) 
Camel milk casein ABTS, 
FRAP, DPPH 
Antioxidant activity 
increased significantly 
Kumar et al. 
(2016a) 
Whole camel milk 
protein hydrolysates 
ABTS, 
FRAP, 
DPPH, Iron 
chelating 
activity 
ABTS, DPPH, and Iron 
chelating activities 
increased, however, FRAP 
did not showed a 
significant enhancement 
upon hydrolysis. 
Al Shamsi et al. 
(2018) 
 
Based on the chemical reactions, the assays determining the antioxidant 
capacity can be categorized into two groups: 1) methods based on electron transfer 
(ET) like the ferric ion reducing antioxidant power (FRAP) and 2,2-diphenyl-1- 
picrylhydrazyl (DPPH) radical-scavenging assay (MacDonald-Wicks et al., 2006, and 
2) methods based on hydrogen atom transfer (HAT) like oxygen radical absorbance 
capacity (ORAC) and total radical trapping antioxidant parameter (TRAP) assay 
(Huang et al., 2005; Sarmadi & Ismail, 2010). 
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2.4.2 Antimicrobial Activity  
 Contamination of food products by pathogenic and spoilage bacteria is of 
significant concern in the food industry. To preserve the shelf life and safety of food 
product as well as to prevent further growth of such bacteria, several methods have 
been employed, which include use of synthetic and natural antimicrobial agents. Due 
to synthetic agents causing a detrimental impact on the human health and the 
environment, manufacturers are incorporating more natural sources of antimicrobial 
agents in the food, but there is a need for novel antimicrobial agents (Brandelli et al., 
2015). Past literature shows a few strategies to improve the antimicrobial activities of 
proteins such as enzymatic hydrolysis (Korhonen & Pihlanto, 2006; Théolier et al., 
2013) and esterification (Sitohy et al., 2013). Another way to produce anti-microbial 
peptides is by the hydrolysis of casein proteins during fermentation with proteolytic 
bacterial strains (Hayes et al., 2006). Furthermore, anti-microbial peptides have also 
been extracted from different cheese varieties (Rizzello et al., 2005; Lignitto et al., 
2012). 
Whey proteins like lactoferrin, lysozyme, lactoperoxidase and 
immunoglobulins are the most studied till date (Chatterton et al., 2006). More recently, 
antibacterial fragments have also been derived from other whey proteins such as α-LA 
and β-LG (Atanasova & Ivanova, 2010). Assessment of antimicrobial potential of 
whey protein hydrolysates and peptides is carried out in vitro. Once the peptide 
sequence is identified and synthesized, the sequences are tested against strains of 
bacteria to affirm the antimicrobial activity (Brandelli et al., 2015). The antimicrobial 
efficacy of the bioactive peptides is influenced by several factors like the load, 
structural diversity (Gennaro & Zanetti, 2000), hydrophobicity (Kustanovich et al., 
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2002), and specific amino acid composition, such as histidine, arginine, proline, 
cysteines and glycine (Andreu & Rivas, 1998). 
Recently, goat whey hydrolysates were produced using alcalase from Bacillus 
licheniformis (Osman et al., 2016) and fractionated by size exclusion chromatography 
(SEC). The hydrolysates showed enhanced antibacterial activity when compared to 
unhydrolyzed goat whey. Another study on goat whey proteins used pepsin enzyme 
which produced peptides with considerable antibacterial activity (El-Zahar et al., 
2004). Théolier et al. (2013) assessed the whey protein isolate hydrolyzed by 
gastrointestinal enzymes. Trypsin and chymotrypsin hydrolysates did not show 
antimicrobial activity, while pepsin derived peptides exhibited considerable activity 
despite their weak degree of hydrolysis. Furthermore, goat whey proteins digested by 
human gastric and duodenal juice have also been investigated and their inhibition 
against pathogenic bacteria has been reported (Almaas et al., 2008).  
Limited studies have been conducted on camel milk proteins and their 
hydrolysates for their antimicrobial activities. Camel caseins were enzymatically 
digested, and the antibacterial activities of the digested sample were evaluated against 
Gram-positive (Listeria monocytogenes, Bacillus cereus, and Staphylococcus aureus) 
and Gram-negative (Escherichia coli) bacteria (Kumar et al., 2016b). It was found that 
casein hydrolysate produced by alcalase showed highest inhibitory activity (17.93 ± 
0.82) against E. coli. Salami et al. (2010) reported that enzymatic hydrolysis of camel 
and bovine whey proteins improved the antimicrobial effects against E. coli, however, 
the degree of hydrolysis with chymotrypsin and trypsin was low, thus the antimicrobial 
activity was not enhanced. There is a need to explore antimicrobial properties of camel 
milk whey protein hydrolysates in-depth using different proteolytic enzymes and 
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experimental conditions and test them against a wide range of pathogenic microbes in 
vitro as well as in vivo.  
2.4.3 ACE Inhibitory Activity  
 Among the bioactive properties demonstrated by the milk bioactive peptides, 
ACE inhibitory activities are widely reported (Phelan & Kerins, 2011).  A dipeptidyl 
carboxypeptidase, ACE catalyzes the conversion of inactive angiotensin I peptide into 
angiotensin II peptide which is a potent vasoconstrictor. Angiotensin II is responsible 
for increasing the salt levels which raises the blood pressure. ACE inhibitor drugs are 
commonly prescribed in individuals suffering from hypertension or related 
cardiovascular disorders (Acharya et al., 2003). Several peptides that inhibit ACE have 
been reviewed and reported after enzymatic hydrolysis of milk proteins and after 
fermentation of milk with Lactobacillus (Hernández-Ledesma et al., 2014). Among 
the most studied ACE-inhibitory peptides are valine-proline-proline [VPP; β-casein 
f(84e86)] and isoleucine-proline-proline [IPP; β-casein f (74e76)] which have been 
derived from bovine caseins following fermentation with Lactobacillus (Solieri et al., 
2015). Moreover, a bovine whey protein concentrate hydrolyzed with alcalase showed 
potent antihypertensive effect (da Costa et al., 2007). 
Studies on the ACE-inhibitory activities of camel milk protein-derived 
peptides are very few and have been summarized in Table 2. Alhaj et al. (2018) 
fermented camel milk using two types of strains (Lactobacillus helveticus or 
Lactobacillus acidophilus with Streptococcus thermophilus) and determined the ACE 
activity of fermented and unfermented camel milk. Pihlanto et al. (2010) also 
investigated fermented camel milk’s inhibitory activity towards ACE. They used LAB 
strains and found seven fermented camel milk samples that showed highest ACE 
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inhibitory activity, along with a correlation between degree of hydrolysis and ACE 
inhibition. ACE-inhibitory peptides can be identified using reversed-phase HPLC (RP-
HPLC) (Mota et al., 2004) or be quantified using triple mass spectrometry (HPLC-
MS3) (Bütikofer et al., 2007). 
Table 2: Antihypertensive activity of camel milk and its protein hydrolysates 
generated by fermentation with probiotic bacteria or exogenous enzymes 
Source Results Reference 
Camel milk fermented with 
Lactobacillus helveticus 130B4 
Peptides purified from 
fermented camel milk 
inhibited ACE 
Quan et al. (2008) 
Camel whole casein + camel 𝛽-
casein (using pepsin, trypsin, 
chymotrypsin and a mixture of 
all three enzymes) 
Increased ACE-inhibitory 
activity 
Salami et al. (2011) 
Peptide fractions from fermented 
camel and bovine milk by 
Lactobacillus rhamnosus PTCC 
1637 
Significantly high ACE-
inhibitory activity of 
cultured camel milk than 
bovine milk 
Moslehishad et al. 
(2013) 
Skimmed camel milk digested 
using pepsin, 𝛼-amylase, and 
pancreatin 
ACE-inhibitory peptides 
released; highest activity for 
post-pancreatic fraction. 
Also, anti-hypertensive 
tripeptide IPP quantified in 
digested camel milk. 
Tagliazucchi et al. 
(2016) 
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2.4.4 Antidiabetic Activity  
Diabetes mellitus affects millions of people around the globe. It is a chronic 
condition in which the body is either unable to produce enough insulin, can’t use the 
produced insulin or a combination of both. Clinical studies and murine models have 
demonstrated that consumption of camel milk by type 1 diabetes patients lowered the 
blood glucose level (Agrawal et al., 2005b, 2007a; Sahani et al., 2005). Although the 
mechanism isn’t fully understood, camel milk appears to have an insulin-like protein 
that resists intestinal digestions, absorbs faster into blood, possesses larger lipid 
micelles and has different casein content (Beg et al., 1986; Ramet, 2001; Agrawal et 
al., 2004a). Agrawal et al. (2007a, 2007b) showed that the lack of camel milk 
coagulation in the human stomach and the influence of small size immunoglobulins of 
camel milk on β-cells have also added to the possible hypoglycemic effect. A recent 
in vitro study reported a potentiating effect of camel milk proteins on insulin receptor 
activity expressed in HEK293 cells, which may be a possible mechanism of action 
(Abdulrahman et al., 2016). Jakubowicz and Froy (2013) suggested that whey proteins 
and their hydrolysates seem to stimulate secretion of gut hormones in vivo by releasing 
bioactive peptides and amino acids, thereby helping mediate glycaemia. Furthermore, 
these peptides can act as dipeptidyl peptidase-4 (DPP-IV) inhibitors in vivo. Since 
DPP-IV inhibition has helped in managing type-2 diabetes, several DPP-IV inhibitory 
peptides have been isolated and identified from bovine casein (Lacroix & Li-Chan, 
2012a, 2013, 2014; Uenishi et al., 2012; Nongonierma & FitzGerald, 2013a, 2013b; 
Silveira et al., 2013) and caprine casein (Zhang et al., 2016). Brandelli et al. (2015) 
summarized in their review paper that DPP-IV inhibitory peptides from hydrolysates 
are more likely to have molecular masses below 2 kDa and most of them contain 
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hydrophobic amino acid residues (Lacroix & Li-Chan, 2012a). 
Much work has been done on diabetic rats treated with raw or fresh camel milk 
where there was significant reduction in plasma glucose levels (Agrawal et al., 2005a, 
2005b; Kamal et al., 2007, Al-Numair et al., 2011, Hamad et al., 2011; Khan et al., 
2013). Camel milk whey protein displayed a significant reduction in blood glucose 
levels from 411 ± 37 mg/dL to 261 ± 25.5 mg/dL in Streptozotocin (STZ)-induced 
diabetic mice (Badr, 2013). The study also reported that diabetic mice treated with 
camel milk whey protein showed higher levels of insulin in comparison to untreated 
diabetic mice. In a recent research article, Mahmoud et al. (2016) demonstrated camel 
whey protein’s protective effects in STZ-induced diabetic pregnant mice’s off-springs. 
It was found that when camel whey protein was administered orally as a supplement 
to diabetic pregnant mice, several postpartum complications like increased levels of 
reactive oxygen species, pro-inflammatory cytokines, overexpression of activating 
transcription factors, and other immune-related functions significantly reduced in the 
offspring. Intact proteins from camel milk and camel whey have been reported to 
possess anti-diabetic property, however, there is no study conducted on bioactive 
peptides produced from camel whey proteins possessing anti-diabetic properties. A 
recent study identified novel DPP-IV inhibitory peptides (Leu-Pro-Val-Pro-Gln and 
Trp-Lys) from camel milk protein hydrolysates, which were not found in bovine milk 
protein hydrolysate. An in-silico approach was undertaken where camel milk protein 
was hydrolyzed with trypsin to obtain potent DPP-IV inhibitory peptides 
(Nongonierma et al., 2017c). Another study identified nine novel DPP-IV inhibitory 
peptides from trypsin digested camel milk proteins, of which two LPVP and MPVQA 
had IC50 values <100 uM (Nongonierma et al., 2018). These studies on camel milk 
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protein hydrolysates provide strong indication that the camel whey protein fraction 
upon hydrolysis might demonstrate effective antidiabetic activities. 
2.4.5 Anticholesterol Activity  
 Studies on dietary proteins derived from soybean (Anderson et al., 1995; 
Carroll & Kurowska, 1995; Potter, 1995; Hori et al., 2001), and fish (Zhang & Beynen, 
1993; Wergedahl et al., 2004) have been proposed to improve blood lipid profile in 
humans and animal experiments. Milk derived bioactive peptides from whey have 
been reported to display similar effects, albeit to a lesser extent. For instance, Nagaoka 
et al. (2001) identified a novel hypocholesterolemic peptide from tryptic digestion of 
𝛽-LG and tested it in Caco-2 cells and animal studies. Liver and serum cholesterol 
levels were markedly lower in rats administered with the tryptic hydrolysate. Inhibition 
of micellar solubility of cholesterol was attributed to be the reason for decrease in 
cholesterol absorption. In another study it was found that the water-soluble lactostatin 
was able to increase cholesterol mechanism by activating the transcription of 
cholesterol 7a-hydroxylase (CYP7A1) gene (Morikawa et al., 2007). 
Previous studies report that bovine casein tends to elevate blood cholesterol 
level due to its high methionine-glycine and lysine-arginine ratios, but the mechanism 
is not understood (Jacobucci et al., 2011). Comparing casein with other proteins like 
soy, fish and whey, it was suggested that these proteins could alter the plasma profile 
by decreasing atherogenesis and having a cardio-protective effect (Erdmann et al., 
2008).  
A study on the effects of fermented camel milk (gariss G) and Gariss 
containing Bifidobacterium (G+Bb+12) on plasma and liver cholesterol levels in rats 
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was performed (Elayan et al., 2010).  Decrease in plasma low-density lipoprotein and 
plasma triglycerides was observed. Also, liver cholesterol levels were much lower in 
rats fed on (G) and (G+Bb+12) diets as compared to rats on positive control 
(cholesterol-enrich) diets.   
Few studies on fermented bovine and camel milk’s cholesterol lowering 
activity have been reported. Damodharan et al. (2016) isolated Lactobacillus 
helveticus strains KII13 and KHI1 from fermented bovine milk. KII13 displayed a 
higher cholesterol-lowering activity (47%) than KHI1 (28%) in vitro. The strain was 
then selected for their in vivo study in atherogenic diet-fed hypercholesterolemic mice. 
Serum total cholesterol and LDL levels showed a decrease in mice fed with fermented 
bovine milk. Also, cholesterol metabolism-related gene expression of LDLR and 
SREBF2 was enhanced in mice fed with KII13. Another study also investigated 
selected LAB strains from raw camel milk (Abushelaibi et al., 2017). Among the 
isolates identified, Lactococcus lactis KX881768, Lactobacillus plantarum 
KX881772, Lactococcus lactis KX881782 and Lactobacillus plantarum KX881779 
were reported to be highly effective in their cholesterol removing abilities.  
2.5 Characterization of Milk Protein Hydrolysates 
Characterization of milk derived protein hydrolysates based on size of the 
peptides, amino acid sequence, chemical modification during processing, storage etc. 
is important. For this, separation, identification, and quantitative determination of 
peptides is needed since peptides are part of complex mixtures (Sharma, 2014).  
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2.5.1 Conventional Methods for Characterizing Protein Hydrolysates 
2.5.1.1 Electrophoretic Methods 
Polyacrylamide gel electrophoresis (PAGE) is widely used in laboratories 
where researchers are studying milk proteins and milk-derived protein hydrolysates. 
The separation here occurs according to the peptides’ mass to charge ratio, isoelectric 
pH, or molecular weight. Thus, there are different types of PAGE which can be used 
according to the separation respectively: native or urea PAGE, isoelectric focusing 
(IEF) or sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).  
Capillary electrophoresis (CE) is another method that allows for a much higher 
accuracy and precision in the quantitative determination of peptides, in contrast to 
conventional PAGE method (Strickland et al., 2001). CE can separate small to large 
sized peptides, making it an attractive option. In a recent study, Omar et al. (2016) 
separated and quantified proteins from camel milk using CE. Three peaks related to 𝛼-
LA, Lf, and serum albumin were identified, while no peak of 𝛽-LG was detected. They 
used bovine milk standards to compare and found 𝛽-LG to be the main whey protein 
in bovine milk followed by 𝛼-LA and bovine serum albumin. Quantification of major 
whey proteins in camel milk showed 𝛼-LA as the main one with a higher concentration 
(2.01 ± 0.02 mg/mL) than that of 𝛼-LA in bovine milk (1.08 ± 0.04 mg/mL). Similarly, 
the major camel casein proteins were quantified, and the results were in accordance 
with the data reported in earlier studies (Al haj & Al Kanhal, 2010; Ereifej et al., 2011) 
2.5.1.2 Chromatographic Methods 
Different chromatographic techniques have been used to characterize protein 
hydrolysates. These include size exclusion-fast protein liquid chromatography and size 
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exclusion-high performance liquid chromatography (HPLC). These techniques can 
determine molecular masses of large to medium sized peptides, while for small sized 
peptides, reversed phase liquid chromatography (RP-HPLC) can be employed 
(Flanagan & FitzGerald, 2002). In RP-HPLC, retention time depends on the amino 
acid composition of small peptides while for larger peptides, retention time is 
influenced by molecular weight and conformational effects. Because RP-HPLC 
profiles of milk protein hydrolysates cover thousands of peptides of different chemical 
and genetic variants, statistical tools help researchers obtain only relevant information 
from such large data (Coker et al., 2005). In the characterization of hydrolysates 
containing large number of peptides, RP-HPLC requires considerable number of 
separation steps to detect a specific peptide without any interference (Tzvetkova et al., 
2007; Noilet & Toldra, 2009). An example of a study where RP-HPLC was used to 
separate and quantify genetic variants of casein and whey protein was done on water 
buffalo milk. They reported separation of all major protein fractions with improved 
resolution, and in a shorter time (Bonfatti et al., 2013).  
2.5.1.3 Mass Spectrometry 
This technique is considered an important tool for analyzing proteins and 
peptides and has advantages like high speed, high sensitivity and small sample size 
over conventional methods. A combination of inlets, ion sources, and mass analyzers 
are utilized for analysis of milk peptides giving configurations like HPLC-
electrospray-quadrupole mass spectrometer, HPLC-electrospray-ion-trap mass 
spectrometry or direct probe matric-assisted laser desorption/ionization-time-of-flight 
mass spectrometer (MALDI-TOF) (Nollet & Toldrá, 2016). 
Quadrupole mass spectrometers can transmit only the ions of a certain 
25 
 
 
 
 
mass/charge ratio (m/z) which reach the detector making it less sensitive. In contrast, 
ions of any m/z can be transmitted and detected in the time of flight (TOF) system 
making it highly sensitive and efficient (Nollet & Toldrá, 2016).  
2.5.2 New Method: Proteomic Analysis of Milk Proteins and Peptides 
Peptide analysis by mass spectrometry involves a proteomic approach to 
characterize milk proteins. The approach can be either gel-based or gel free technique. 
In gel-based approach, protein fraction retained at specific molecular weight is 
separated, the protein digestion takes place using enzymes, and finally sequencing of 
the obtained peptides is done by mass spectrometry or in combination with another 
separation technique (HPLC/CE). This approach has limitations like analyzing 
proteins of very low or very high molecular masses, and extreme isoelectric point or 
hydrophobicities (Nollet & Toldrá, 2016). A second proteomic approach involves 
digestion of all proteins in solution, followed by fractionation of peptides by 2D 
chromatography, and then identification of the peptides by mass spectrometry 
(O’donnell et al., 2004; Guy & Fenaille, 2006). 
26 
 
 
 
 
Chapter 3: Methods 
 
3.1 Enzymes and Reagents 
 Pepsin from porcine gastric mucosa (EC 3.4.23.1, 250 units/mg protein), 𝛼-
chymotrypsin from bovine pancreas (EC 3.4.21.1, ≥40 units/mg protein), trypsin from 
bovine pancreas (EC 3.4.21.4, ≥8.500 units/mg), angiotensin-I converting enzyme 
(ACE) from rabbit lung (E.C 3.4.15.1, ≥2.0 units/mg protein), α-Glucosidase from 
Saccharomyces cerevisiae (type I, lyophilized powder, >10 units/mg protein, EC 
3.2.1.20), α-amylase from porcine pancreas (EC 3.2.1.1), DPP-IV from human (EC 
3.4.14.5), porcine pancreatic lipase (EC 3.1.1.3), cholesterol esterase enzyme (porcine 
pancreas, EC 3.1.1.13, ~35 U/mg) were purchased from Sigma-Aldrich Chemical 
Company (St. Louis, MO, U.S.A). 
Chemical reagents including acetonitrile, methanol of HPLC grade, 
trifluoroacetic acid (TFA), 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid 
(Trolox), o-phthaldialdehyde (OPA), 2,2-azinobis (3-ethylbenzthiazoline-6-sulfonic 
acid) (ABTS), 2,2-diphenyl-1-picrylhydrazyl (DPPH) and purified bovine milk 
standards (over 90% purity) were obtained from Sigma-Aldrich (USA). Other 
chemicals were purchased from BDH middle east and were of analytical grade. All 
solutions were prepared using deionized water and kept at 4°C until further use.   
3.2 Camel Milk Sample Collection  
Raw camel milk was procured from local camel farms in Al Ain, United Arab 
Emirates (UAE). Milk was collected from 3-4 healthy female camels (Camelus 
dromedarius, local breed) and pooled together to be used as a composite sample. Milk 
was then transported to the Laboratory at Food Science Department, UAEU in chilled 
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condition. After arrival in the laboratory, the samples were stored at 4°C and processed 
no later than 2 hrs. 
3.3 Camel Whey Protein Separation 
 Camel milk was skimmed via centrifugation at 4700 x g for 10 min, at 15°C 
using a refrigerated centrifuge (Beckman Coulter, Allegra X-30R). The pH of 
skimmed milk was adjusted to 4.6 with 6 N HCl using a digital pH meter (Starter 3100, 
Ohaus, USA) and allowed to settle for 1 h. This was followed by centrifugation at 4700 
x g at 4°C for 10 min which resulted in casein pellets and whey supernatant. Collected 
whey supernatant was once again centrifuged to remove any remaining casein 
fractions. One portion of the whey protein fraction was kept as control, whereas the 
remaining portion was distributed in three batches for enzymatic hydrolysis by each 
enzyme. 
3.4 Production of Camel Whey Protein Hydrolysates 
 Hydrolysis of camel whey proteins was carried out by using three proteolytic 
enzymes - pepsin, trypsin and chymotrypsin. Enzymatic hydrolysis was carried out at 
the optimal conditions of pH and temperature for each enzyme (Table 3) (Osman et 
al., 2016).  
Table 3: Hydrolysis conditions for production of camel whey protein hydrolysates 
Enzyme Enzyme/substrate ratio pH Time (h) Temperature 
(°C) 
Pepsin 1/100 4.0 3, 6 37 
Chymotrypsin 1/100 8.0 3, 6 55 
Trypsin 1/100 8.0 3, 6 55 
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Whey proteins were divided into six groups with three replicates each for each type of 
hydrolysate. The protein content in each hydrolysate was determined by Biuret test 
and found to be 3.07%. The enzymatic solution was prepared by solubilizing known 
concentration of the enzymes in 25 ml of whey samples in order to obtain an enzyme: 
substrate ratio of 1:100.  The pH of whey samples was adjusted to the optimum value 
for each enzyme (pH 2 for pepsin and 8 for trypsin and chymotrypsin) and monitored 
by a digital pH meter (Starter 3100, Ohaus, Parsippany, NJ). Then, the whey samples 
were heated to an optimal temperature for each enzyme (37°C for pepsin and 55°C for 
trypsin and chymotrypsin) in a Vaseline bath under constant agitation (752A model, 
Fisatom, São Paulo, SP, Brazil). The samples were incubated for 3 h and 6 h of 
hydrolysis time for each enzyme and thereafter the enzymes were heat deactivated at 
95°C for 10 mins. The samples were centrifuged (10,000 x g, 15 min, 4°C) and 
supernatant was collected and stored at -20°C for further analysis.  
3.5 Characterization of Camel Whey Protein Hydrolysates 
3.5.1 Degree of Hydrolysis 
Degree of hydrolysis (DH) was analyzed using the o-phthalaldehyde (OPA) 
method described by Nielsen et al. (2001) and Donkor et al. (2007) with a few 
modifications. The OPA reagent was prepared freshly by combining 25 ml of sodium 
tetraborate buffer (100 mM; pH 9.3), 2.5 mL of sodium dodecyl sulfate SDS (20%, 
wt/wt), 40 mg of OPA (dissolved in 1 mL of methanol), and 100 µL of β-
mercaptoethanol and diluted to 50 mL with water. The serine standard (0.9516 meqv/l) 
was prepared by dissolving 50 mg serine (Sigma Aldrich, USA) in 500 mL deionized 
water. Three milliliters of 0.75 M trichloroacetic acid (TCA) was added to 3 mL 
aliquots of whey samples; and incubated for 10 min at room temperature. The mixture 
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was centrifuged at 4000 x g for 30 min at 4°C The supernatant was passed through a 
0.45 µm syringe filter and stored at 20°C until assayed. Small aliquots (100µL) of the 
samples were added to a test tube containing 1 ml of the OPA reagent and mixed gently 
for 5 seconds. The absorbance (Asample) was measured at 340 nm using a NovaSpec-II 
Spectrophotometer (Pharmacia, England, UK) after exactly two minutes of incubation 
at room temperature. The experimental steps were repeated with milli-Q water as a 
blank (Elix-10, Millipore, Molsheim, France) and with the serine solution as standard 
(Astandard). Degree of hydrolysis was determined by using DH (%) =h/ htot x 100 where, 
htot was the total number of peptide bonds per protein equivalent and h was the number 
of hydrolysed bonds, which was determined by using h = (Serine NH2 – β)/α.  
3.5.2 Reversed-Phase High-Performance Liquid Chromatography  
The method described by Bobe et al. (1998) with slight modifications was used 
to characterize the non-hydrolyzed and hydrolyzed camel whey proteins on RP-HPLC 
system (Thermoscientific, Germering, Germany). Protein analysis was performed on 
a Reversed Phase Column C-18 (250 mm length x 4.6 mm internal diameter) 
(Thermoscientific, Germering, Germany). Camel whey and whey hydrolysate samples 
(30 mg/mL) were dissolved in solvent (acetonitrile, water, and trifluoroacetic acid in 
a ratio 100:900:1 (v/v/v)) and using a 0.45 µm cellulose acetate filter, insoluble 
particles were removed by filtration. The filtrate was injected (5 µL) on the column. 
Chromatographic separation was performed in reverse phase mode using a C-18 
column maintained at 25°C with a flow rate of 1 mL/min, using a linear acetonitrile 
gradient, starting with 2.5 min 100% buffer A (water, 0.13% TFA), followed by a 
linear gradient to 40% buffer B (100% acetonitrile, 0.13% TFA) for 10 min. The 
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detection wavelength was 220 nm. Analysis of whey protein hydrolysate produced by 
different enzymes for 3 and 6 h was carried out.  
3.6 Different Bioactivities of Camel Whey Protein Hydrolysates 
3.6.1 Antioxidant Activity  
3.6.1.1 DPPH Radical Scavenging Activity 
 DPPH radical-scavenging activity was determined by the method described by 
Wu et al. (2003). To the sample (1.5 mL), 1.5 mL of 0.15 mM 2,2-diphenyl-1-picryl 
hydrazyl (DPPH) in 95% ethanol was added and vigorously mixed. The mixture was 
then allowed to stand at room temperature in the dark for 30 min. The absorbance was 
measured at 517 nm using a UV-1800 spectrophotometer (Shimadzu, Kyoto, Japan). 
Preparation of the blank was same, except that the sample was replaced with distilled 
water. A standard curve of Trolox in the range of 10–60 μM was prepared and the 
activity was expressed as μmol Trolox equivalents (TE)/g protein of hydrolysate.  
3.6.1.2 ABTS Radical Scavenging Activity 
 ABTS radical scavenging activity was assayed as per the method of Arnao et 
al.  (2001) with a slight modification. The stock solutions included 7.4 mM ABTS 
solution and 2.6 mM potassium persulphate solution. The working solution was 
prepared by mixing the two stock solutions in equal quantities and allowing them to 
react for 12 h at room temperature in the dark. The solution was then diluted by mixing 
1 mL ABTS solution with 50 mL methanol to obtain an absorbance of 1.1 ± 0.02 units 
at 734 nm using a UV-1601 spectrophotometer (Shimadzu, Kyoto, Japan). A fresh 
ABTS solution was prepared for each assay. Samples (150 μL) with a concentration 
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range of 0.5–10 mg/l were mixed with 2850 μL of ABTS solution and the mixture was 
left at room temperature for 2 h in dark. The absorbance was then measured at 734 nm 
using the spectrophotometer. A sample blank at each concentration was prepared in 
the same manner except that methanol was used instead of ABTS solution. A standard 
curve of Trolox ranging from 50 to 600 μM was prepared. The activity was expressed 
as μmol Trolox equivalents (TE)/mL of phenolic compounds. 
3.6.1.3 FRAP Assay 
 The reducing ability of hydrolyzed whey was measured using the ferric 
reducing/antioxidant power (FRAP) assay by the method of Benzie and Strain (1996) 
as modified by Maqsood and Benjakul (2010). Working FRAP reagent was prepared 
by mixing 2.5 mL of 10 mM TPTZ (2,4,6-tripyridyl-s-triazine) solution in 40 mM HCl 
plus 2.5 mL of 20 mM FeCl3. 6H2O and 25 mL of 0.3 mM acetate buffer (pH 3.6). 
Aliquots of 3.0 mL each of freshly prepared FRAP reagent were mixed with 0.3 mL 
of distilled water and 0.1 mL of hydrolyzed whey protein samples (45 mg/mL). 
Absorbance (593 nm) of sample as well as blank solutions was taken at 30 s intervals 
for up to 8 min. Sample FRAP values were calculated based on Trolox standard curve 
prepared with 10-60 μM and were expressed as Trolox equivalent (μM). 
3.6.1.4 Ferrous Ion Chelating Activity 
 The chelation of Fe2+ was measured using the method of Boyer and McCleary 
(1987), with slight modification. Diluted whey hydrolysate samples (4.7 mL) were 
mixed with 0.1 mL of 2 mM FeCl2 and 0.2 mL of 5 mM ferrozine. The reaction 
mixture was made to stand for 20 min at room temperature. The absorbance was then 
read at 562 nm. The blank was prepared by using the distilled water instead of the 
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sample. The chelating activity was calculated as follows: Chelating activity (%)=[(B-
A)/B] ×100, where A is absorbance of the sample and B is absorbance of the blank. 
3.6.2 Antimicrobial Activity 
 The antimicrobial activity of camel whey protein hydrolysates (CWPHs) was 
evaluated as per the method of Shavandi et al. (2017) and Esmaeilpour et al. (2017) 
with some modifications. Five common human pathogenic bacterial strains including 
two Gram positive (Staphylococcus aureus ATCC 15923 and Listeria monocytogenes 
ATCC 7644 (Sigma-Aldrich, USA) and three Gram negative bacteria (Salmonella 
typhimurium ATCC 14028, Cronobacter sakazakii ATCC 29544 and Escherichia coli 
ATCC 35218 ESBL (Sigma-Aldrich, USA) were used as indicator organisms. 
Indicator micro-organisms were incubated overnight in Mueller Hinton broth (MHB) 
medium at 37°C and working cultures were obtained by diluting to approximately 6.0 
log CFU/mL using sterile MHB medium. The antimicrobial activity was assessed by 
observing growth of indicator micro-organisms in presence or absence of test samples 
in a sterile 96-well microplate after 24 h of incubation at 37°C. For this, 100 μL of 
indicator micro-organism was mixed with 50 μL of test sample and 50 μL of fresh 
MHB medium. For control, test sample was replaced with 50 μL of sterile water. The 
optical density of wells was measured at 0 h and 24 h (37°C) at 595 nm using a 
microplate reader (AMP Platos R 496, Austria). Percent inhibition after 24 h of 
incubation was calculated according to Casey et al. (2004):  
% growth inhibition = (control -test)/ control x 100.  
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3.6.3 Antihypertensive Activity  
ACE inhibition activity of the whey protein hydrolysates was determined by 
an HPLC method modified from Rufián-Henares and Morales (2007). ACE-inhibitory 
activity is quantified by hippuric acid formation in vitro by causing hippuryl-histidyl-
leucine (HHL) to interact with the ACE from rabbit lung, both in the presence and 
absence of inhibitor. 50 μL of ACE solution (20 mU) was added to 150 mM borate 
buffer (pH 8.3, 300 mM NaCl), along with 50 μL of sample solution, and 50 μL of 20 
mM HHL as substrate. This mixture was incubated for 30 min at 37°C. The reaction 
was terminated with 1 mL of 1.75 M HCl. Hippuric acid released upon enzymatic 
reaction was analyzed using high performance liquid chromatography. The analysis of 
hippuric acid in samples was performed using a C18 (4.6 mm ID x 25 cm, particle size, 
5 µm) (Supelco SIl LC-SI) attached with a guard column (12.5 mm analytical guard 
column, Thermo Fisher Scientific Inc., CA, USA). The mobile phase consisted of an 
isocratic system of 12.5% (v/v) methanol in HPLC grade water, flow rate was 0.3 
mL/min, the run lasted for 9 min and the temperature of the column oven was adjusted 
at 20°C. Detection was carried with UV–Vis photodiode array detector at a wavelength 
of 228 nm. Samples 5 µL were injected onto the HPLC system. Standard calibration 
curve was created with different hippuric acid concentration solubilized in sodium 
borate buffer (1-1000 µg/mL). The data collected was processed by the Chromeleon 
6.8 Chromatography Data System (Dionex Corporation 1228 Titan Way, Sunnyvale, 
CA, USA). 
The percent inhibition of enzyme activity was calculated as follows: 
% ACE inhibition = (
𝐻𝑖𝑝𝑝𝑢𝑟𝑖𝑐 𝑎𝑐𝑖𝑑 (𝑐𝑜𝑛𝑡𝑟𝑜𝑙)−𝐻𝑖𝑝𝑝𝑢𝑟𝑖𝑐 𝑎𝑐𝑖𝑑 (𝑡𝑒𝑠𝑡)
𝐻𝑖𝑝𝑝𝑢𝑟𝑖𝑐 𝑎𝑐𝑖𝑑 (𝑐𝑜𝑛𝑡𝑟𝑜𝑙)
) x 100 
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3.6.4 Antidiabetic Activity  
3.6.4.1 α- Glucosidase Inhibition 
 α-glucosidase inhibition was assessed according to the method reported by 
Zhang et al. (2011) with minor modifications. Approximately 80 μL of whey 
hydrolysate samples was added to 100 μL of 4-nitrophenyl-β-D-glucuronide (10 mM 
PNPG dissolved in 0.1 M sodium phosphate buffer, pH 6.8). The reaction was initiated 
by addition of 20 μL enzyme solution (1 U/mL) followed by 10 min incubation at 37°C 
Then, 200 μL of the reaction mixture was taken and transferred to a 96-well plate. To 
measure the release of p-nitrophenol from PNPG, the absorbance was read at 405 nm 
by microplate reader (Epoch 2, BioTek, VT, USA). Triplicate measurements for each 
sample were carried out. α-glucosidase inhibition (%) was calculated using the 
following equation-  
α-glucosidase inhibition % = [ 1- { 
𝐴(𝑠𝑎𝑚𝑝𝑙𝑒)−𝐴(𝑏𝑙𝑎𝑛𝑘)
𝐴(𝑡𝑒𝑠𝑡)−𝐴(𝑐𝑜𝑛𝑡𝑟𝑜𝑙)
 } ] * 100 
where, A(sample) = absorbance of the mixture of whey sample, PNPG solution and 
enzyme,  
A(blank) = absorbance of the mixture of whey sample and PNPG solution without 
enzyme, 
A(test) = absorbance of the mixture of buffer (instead of sample), PNPG solution and 
enzyme and  
A(control) = absorbance of the mixture of buffer and PNPG solution without enzyme  
3.6.4.2 α- Amylase Inhibition 
 α-amylase inhibition was measured according to the method described by 
Chinedum et al. (2018). Approximately 40 μL of whey hydrolysate sample was diluted 
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with 160 μL of distilled water and mixed with 400 μL of 4% starch solution in a 
centrifuge tube. Next, 200 μL of the enzyme solution (30 unit/ml) was added and 
incubated at 25°C for 3 minutes. From this mixture, 200 μL was taken and added into 
a separate tube containing 100 μL 3,5- dinitrosalicylic acid (DNS) color reagent 
solution (96 mM DNS; dissolved in 5.31 M of potassium tartarate in 2 M NaOH). The 
reaction was terminated by incubating at 95°C for 10 minutes. Then, 900 μL of 
distilled water was added, and the mixture was vortexed. To a 96-well plate, 200 μL 
of the reaction mixture was added, and the absorbance was read at 540 nm using a 
microplate reader (Epoch 2, BioTek, VT, USA). The experiment was carried out in 
triplicates and α-amylase inhibition % was calculated as follows- 
α-amylase inhibition % = [ 1- { 
𝐴(𝑠𝑎𝑚𝑝𝑙𝑒)−𝐴(𝑏𝑙𝑎𝑛𝑘)
𝐴(𝑡𝑒𝑠𝑡)−𝐴(𝑐𝑜𝑛𝑡𝑟𝑜𝑙)
 } ] * 100 
where A(sample) = absorbance of the mixture of whey sample, starch solution, enzyme 
and DNS color reagent solution, 
A(blank) = absorbance of the mixture of whey sample, starch solution and DNS color 
reagent without enzyme, 
A(test) = absorbance of the mixture of buffer (instead of sample), starch solution, 
enzyme and DNS color reagent, 
A(control) = absorbance of the mixture of buffer, starch solution and DNS color 
reagent without enzyme  
3.6.4.3 DPP-IV Inhibition 
 DPP-IV inhibitory activity was measured using the method described by 
Lacroix and Li-Chan (2013). About 25 μL of 1 mM Gly-Pro-p-nitroanilide (substrate), 
50 μL DPP-IV (10 U/mg), 100 μL of 0.1 M Tris-HCl buffer (pH 8.0), and whey 
samples (50 and 100 μL) were added and incubated for 90 minutes at 37°C. The 
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reaction was terminated by adding 100 μL of 1 M sodium acetate buffer (pH 4.0). The 
absorbance of the released p-nitroanilide was read at 405 nm using a microplate reader 
(Epoch 2, BioTek, VT, USA). Each sample was analyzed in triplicate, and sample 
blanks were included where Tris-HCl buffer was replaced with DPP-IV. Tris-HCl 
buffer was used as negative control and positive control was prepared with DPP-IV 
solution instead of sample. The DPP-IV inhibition rate was calculated as:  
% DPP-IV inhibition = (1- 
A(sample)−A (sample blank)
A (positive control)−A (negative control) 
 ) x 100 
where A (sample) = absorbance of the mixture of whey sample, substrate, DPP-IV 
enzyme and Tris-HCl buffer 
A (blank) = absorbance of the mixture of whey sample, substrate and Tris-HCl buffer 
without enzyme 
A (positive control) = absorbance of the mixture of substrate, DPP-IV enzyme and 
Tris-HCl buffer, 
A (negative control) = absorbance of the mixture of substrate, and Tris-HCl buffer 
without enzyme and whey sample 
3.6.5 Lipase Inhibition Activity  
 The lipase inhibition assay was conducted as per the method described by 
Badmaev et al. (2015) with some modifications. The reagents prepared were Tris 
buffer A 100 mM/L Tris-HCl (pH 6.8), 5 mM/L CaCl2, and 1 mM/L disodium salt of 
ethylenediaminetetraacetic acid (Na2EDTA). About 10 mM/L of 3-(N-morpholino) 
propansulfonic acid (MOPS) solution was added to porcine pancreatic lipase (EC 
3.1.1.3, Sigma) to make the concentration 1000 U/mL. For the enzyme solution, 850 
μL of Tris buffer was added to 30 μL of porcine pancreatic lipase solution, while for 
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the substrate solution, N, N-dimethylformamide was added to 4-nitrophenyl butyrate 
to make the concentration as 40 mM/L. Finally, the test article solution was prepared 
by mixing N, N-dimethylformamide and Tris buffer at a ratio of 1:4. Then, 100 μL of 
sample and 880 μL of enzyme solution was added to the microplate and incubated at 
37°C for 15 min. Following this, 20 μL of substrate solution was added to start the 
enzymatic reaction at 37°C. The absorbance was measured at 405 nm every minute for 
15 min using microplate reader (Epoch 2, BioTek, VT, USA). The experiment was 
performed in triplicates. The percentage of lipase inhibition was calculated by the 
following equation: 
                 % Lipase inhibition = [1 – (B – b) / (A – a)] x 100 
where, A is the activity in the absence of the inhibitor; a is the negative control in the 
absence of inhibitor; B is the activity in the presence of the inhibitor; and b is the 
negative control in the presence of the inhibitor.  
3.6.6 Cholesterol Esterase Inhibition Activity 
The pancreatic cholesterol esterase inhibition was assayed using a modified 
method as described by Myers et al. (1955). CWPHs (50 µL) was incubated with 
substrate mixture (100 µL) containing 5.16 mM taurocholic acid, 2 mM cholesteryl 
acetate in 100 mM sodium phosphate buffer, and 100 mM NaCl. The reaction was 
initiated by adding 100 µL of porcine pancreatic cholesterol esterase (5 μg/mL). After 
incubation for 30 min at 37°C, the reaction was terminated by addition of 1M HCl. 
Cholesterol released upon enzymatic hydrolysis of cholesteryl acetate was extracted 
three times using hexane and was determined by using reverse-phase high performance 
liquid chromatography (RP-HPLC) (Thermoscientific dionex ultimate 3000, 
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Germering, Germany) following the method described by Prates et al. (2006) with 
modification. The analysis of cholesterol in samples were performed using a normal-
phase silica column (4.6 mm ID x 25 cm, particle size, 5 µm) (SUPELCOSIL LC-Si) 
attached with a guard column (12.5 mm analytical guard column, Thermo Fisher 
Scientific Inc., CA, USA). The mobile phase consisted of 1% (v/v) isopropanol in n-
hexane, flow rate was 1 mL/min, the run lasted for 7 min and the temperature of the 
column oven was adjusted at 20°C. Detection was carried with UV–Vis photodiode 
array detector at a wavelength of 202 nm. Samples (5 to 10 µL) were injected onto the 
HPLC system. Standard calibration curve was generated with different cholesterol 
concentration solubilized in hexane. The data was collected and processed by the 
Chromeleon® Chromatography Data System 7.0 (Dionex UltiMate 3000 RS Diode 
Array detector) included in the HPLC system. The percent inhibition of enzyme 
activity was calculated as follows: 
% Cholesterol esterase inhibition =  
𝑐𝑜𝑛𝑡𝑟𝑜𝑙−𝑡𝑒𝑠𝑡
𝑐𝑜𝑛𝑡𝑟𝑜𝑙
 * 100 
3.7 Statistical Analysis 
 Camel whey proteins prepared from milk of female camels was pooled together 
and hydrolyzed separately to produce three different sets of hydrolysates for each 
enzyme tested, which served as three replicates. The data were subjected to one-way 
analysis of variance (ANOVA) using SPSS 12.0 software (SPSS INC., Chicago, IL, 
USA,2002). Significant treatment means were separated by Duncan’s New Multiple 
Range Test.  
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Chapter 4: Results 
 
4.1 Characterization of Camel Whey Protein Hydrolysates 
4.1.1 Degree of Hydrolysis (DH) 
Degree of hydrolysis (DH) of camel whey protein hydrolysates were expressed 
in terms of percentage (%) of hydrolysis carried out by each enzyme on the protein 
substrate as shown in Figure 1.  
 
 
 
 
 
 
 
 
 
 
Figure 1: Degree of hydrolysis (DH) % of camel whey protein hydrolysates produced 
by gastric and pancreatic enzymes after 3 and 6 h of hydrolysis. Keynotes: P3- 
pepsin (3h), P6- pepsin (6h), C3- chymotrypsin (3h), C6- chymotrypsin (6h), T3- 
trypsin (3h), T6- trypsin (6h). Data represent mean ± SD (n = 3). Different lowercase 
letters indicate significant differences (P < 0.05) among the hydrolysates 
 
DH of camel whey proteins varied from 8.54% to 47.53%, with chymotrypsin 
(C6) derived hydrolysates displaying the highest DH (47.53% ± 7.7), and trypsin (T3) 
derived hydrolysates showing the lowest DH (8.54% ± 0.94). DH for each enzyme 
increased with increase in time of hydrolysis from 3 to 6 hrs. It was observed that at 3 
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h, all enzymes produced peptides with similar degree of hydrolysis (~10%) with no 
significant difference between them (P > 0.05). Further hydrolysis (i.e. up to 6 h) 
resulted in an increase of DH (%) for all 3 enzyme-generated hydrolysates. There was 
a one-fold increase in DH for peptic hydrolysates and nearly a two-fold increase for 
chymotryptic hydrolysates. Chymotrypsin (C6) produced hydrolysates depicted 
47.53% ± 7.7 DH, followed by pepsin (P6) (24.58% ± 3.67) and trypsin (T6) (14.49% 
± 0.88) produced hydrolysates after 6 h of hydrolysis.  
4.1.2 RP-HPLC 
HPLC chromatogram of camel whey and camel whey protein hydrolysates 
(CWPHs) generated pepsin, trypsin and chymotrypsin after 3 and 6 h is shown in 
Figure 2. In the intact camel whey proteins (W), an intact peak belonging to α-LA was 
detected at 5.5 min retention time. 
 
 
 
 
 
 
 
 
 
Figure 2: Reversed-phase high performance liquid chromatography (RP-HPLC) 
profile of camel whey and camel whey protein hydrolysates produced by pepsin, 
trypsin and chymotrypsin after 3 and 6 h of hydrolysis. Key notes: W- intact camel 
whey proteins, P3- pepsin (3h), P6- pepsin (6h), C3- chymotrypsin (3h), C6- 
chymotrypsin (6h), T3- trypsin (3h), T6- trypsin (6h). 
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Upon hydrolysis, clear small peaks were seen for all six hydrolysates between 
the retention time 2.5 – 4.6 minutes, which were generated due to the complete 
degradation of α-LA. These peaks represented the shorter peptides which were 
produced following enzymatic digestion. Higher degree of hydrolysis with generation 
of intense smaller peptides distributed over a wide range of hydrophobicity and 
molecular weight was observed in chymotrypsin (C3 & C6) and pepsin (P3 & P6) 
generated CWPHs, which was also reflected by the DH results (Figure 1), where 
chymotrypsin and pepsin displayed a higher DH than trypsin generated hydrolysates 
at 6 h. On the other hand, trypsin (T3 & T6) showed some traces of α-LA, as well as 
lesser amounts of small peptides (Figure 2). Thus, trypsin derived CWPHs displayed 
less intense shorter peptide peaks which were distributed within a narrow range of 
hydrophobicity. Overall, chymotrypsin derived CWPHs showed highest detector 
response for the shorter peptide peaks, followed by pepsin and trypsin CWPHs.   
4.2 Antioxidant Activity of Camel Whey Protein Hydrolysates 
4.2.1 DPPH Radical Scavenging Activity 
The DPPH radical scavenging activity of camel whey protein and its 
hydrolysates is depicted in Figure 3. The results showed that different CWPHs 
generated with different enzymes demonstrated different radical scavenging potential. 
Hydrolysates from chymotrypsin had the highest scavenging activity followed by 
trypsin (P < 0.05). Chymotrypsin derived CWPHs showed a significant increase in 
scavenging activity from 3 to 6 h (415.5 ± 1.16 and 618.59 ± 0.89 μmol TE/g of 
sample, respectively) (P < 0.05). 
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Figure 3: DPPH radical scavenging activity (μmol of trolox equivalents (TE)/g) of 
camel whey protein (W) and camel whey protein hydrolysates (CWPHs) produced 
by pepsin, chymotrypsin and trypsin after 3 and 6 h of hydrolysis. Data represent 
mean ± SD (n = 3). Different letters (a–d) above bars represent a significant 
difference (P < 0.05) among different CWPHs. 
 
In contrast, antioxidant effects of trypsin hydrolysates decreased after 6 h (from 
396.7 ± 0.35 μmol TE/g of sample to 324.5 ± 1.21 μmol TE/g of sample). Pepsin 
generated hydrolysates also didn’t show any major increase in their scavenging 
activity. However, hydrolysates from both chymotrypsin and trypsin exhibited higher 
DPPH radical scavenging activity than the unhydrolyzed whey (W). Overall, 
chymotrypsin generated CWPHs displayed higher and pepsin derived CWPHs had 
lowest scavenging activities (P < 0.05). 
4.2.2 ABTS Radical Scavenging Activity 
ABTS radical scavenging activity displayed by camel whey proteins and its 
hydrolysates is depicted in Figure 4. Intact whey protein had the lowest ABTS 
scavenging activity (7.1 ± 0.32 μmol TE/g of sample). After hydrolysis, all CWPHs 
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proved to be efficient scavengers of ABTS radical (P < 0.05). Most efficient were the 
hydrolysates from chymotrypsin (84.5 ± 0.11 μmol TE/g of sample) with no significant 
difference when the hydrolysis time increased from 3 to 6 h (P > 0.05). 
 
 
 
 
 
 
 
 
Figure 4: ABTS radical scavenging activity (μmol of trolox equivalents (TE)/g) of 
camel whey protein (W) and camel whey protein hydrolysates (CWPHs) produced 
by pepsin, chymotrypsin and trypsin after 3 and 6 h of hydrolysis. Data represent 
mean ± SD (n = 3). Different letters (a–d) above bars represent a significant 
difference (P < 0.05) among different CWPHs. 
 
Trypsin generated CWPHs were the second most effective hydrolysates with 
69.8 ± 0.19 μmol TE/g of sample of ABTS radical scavenging activity at 3 h, and a 
one-fold increase was observed at 6 h (79.2 ± 0.13 μmol TE/g of sample). Lowest 
ABTS radical scavenging activity among the hydrolysates, were found in the pepsin 
generated CWPHs which increased from 3 h (22.9 ± 0.34 μmol TE/g of sample) to 6 
h (26.4 ± 0.92 μmol TE/g of sample) of hydrolysis time. Overall, all enzyme generated 
CWPHs had higher ABTS radical scavenging activity when compared to intact camel 
whey proteins, with chymotrypsin hydrolysates showing the highest activity and 
pepsin hydrolysates showing the lowest.  
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4.2.3 Ferric Reducing Antioxidant Power (FRAP) Assay 
The FRAP assay was carried out on camel whey protein and its hydrolysates, 
and results are graphically represented in Figure 5. The reducing power varied 
significantly between all camel whey protein hydrolysates (CWPHs) and intact camel 
whey protein (W) (P < 0.05). 
 
 
 
 
 
 
 
 
Figure 5: Ferric-reducing antioxidant power (FRAP) (μmol of trolox equivalents 
(TE)/g) of camel whey protein (W) and camel whey protein hydrolysates (CWPHs) 
produced by pepsin, chymotrypsin and trypsin after 3 and 6 h of hydrolysis. Data 
represent mean ± SD (n = 3) from 3 replicates. Different letters (a–d) above bars 
represent a significant difference (P < 0.05) among different CWPHs. 
 
 Compared to intact camel whey, only pepsin hydrolysates had slight 
improvement in their reducing power at 3 and 6 h (550.6 ± 9.51 μmol TE/g of sample) 
(P < 0.05). The hydrolysates from chymotrypsin and trypsin showed no increase in 
reducing power than intact camel whey. In fact, tryptic hydrolysates displayed very 
poor reducing power even at longer hydrolysis time (422.4 ± 8.71 μmol TE/g of 
sample), when compared with camel whey. Although pepsin hydrolysates had 
significant activity, overall, there was no enhancement in reducing power for any of 
the hydrolysates from three enzymes when compared to camel whey protein.  
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4.2.4 Ferrous Ion Chelating Activity 
Ferrous ion chelation activity of camel whey protein and its hydrolysates is 
presented in Figure 6. There was a significant increase in the chelating activity 
displayed by camel whey protein hydrolysates after hydrolysis (P < 0.05). Ferrous ion 
chelating activity increased for trypsin derived hydrolysates with hydrolysis time from 
3 to 6 h (52.1% to 65.3%, respectively) (P < 0.05), while pepsin (P3) and chymotrypsin 
(C3, C6) hydrolysates didn’t show significant difference in their chelating activity (P 
> 0.05). Trypsin generated hydrolysates after 6h was able to increase the metal 
chelating activity by 4 times compared to intact whey proteins (W). 
 
 
 
 
 
 
 
 
Figure 6: Ferrous ion-chelating activity (%) of camel whey protein (W) and camel 
whey protein hydrolysates (CWPHs) produced by pepsin, chymotrypsin and trypsin 
after 3 and 6 h of hydrolysis. Data represent mean ± SD (n = 3) from 3 replicates. 
Different letters (a–d) above bars represent a significant difference (P < 0.05) among 
different CWPHs. 
 
 It was observed that the chelating activity for CWPHs from pepsin decreased 
to 20% after 6 h. Intact camel whey (W) showed 14.8% chelation of ferrous ions. Thus, 
trypsin derived CWPHs had the highest ferrous ion chelating activity, while pepsin 
derived CWPHs at 6 h had the lowest activity among the hydrolysates produced.  
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4.3 Antimicrobial Activity of Camel Whey Protein Hydrolysates 
The antimicrobial activity of camel whey protein and its hydrolysates against 
2 Gram-positive and 3 Gram-negative bacteria is given in Table 4. For Cronobacter 
sakazakii, the inhibition % varied from 22.42% ± 0.39 to 51.59% ± 0.72. The highest 
antimicrobial activity was shown by both pepsin and trypsin hydrolysates at 6 h (P > 
0.05). Pepsin (P3) derived CWPHs had 41.98% ± 0.59 growth inhibition activity which 
increased to 51.59% ± 0.72 after 6 h of hydrolysis (P < 0.05). Similarly, an increase in 
antimicrobial activity was seen for trypsin hydrolysates from 3 to 6 h (27.49% ± 0.85 
to 49.62% ± 3.62). Although chymotrypsin hydrolysates showed good antimicrobial 
activity, their activity decreased from 3 to 6 h of hydrolysis (from 46.72% ± 3.68 to 
33.29% ± 0.46). For all CWPHs, the antimicrobial activity was enhanced in 
comparison to intact whey. Hence, pepsin (P6) and trypsin (T6) derived CWPHs at 6 
h of hydrolysis time demonstrated the highest antimicrobial activity, while trypsin (T3) 
CWPHs showed the lowest at 3 h.  
Like C. sakazakii, intact whey proteins and trypsin generated hydrolysate (6 h) 
showed similar antimicrobial activity against Listeria monocytogenes (P > 0.05). 
Among all the hydrolysates, pepsin generated hydrolysates had the highest 
antimicrobial activity at 6 h (81.49% ± 2.05) against L. monocytogenes. Pepsin derived 
CWPHs showed an increase in the antimicrobial activity from 3 to 6 h against L. 
monocytogenes. The lowest activity was displayed by trypsin hydrolysates at 6 h 
(29.95% ± 0.05), which was not significantly different to intact whey’s inhibition 
activity (P > 0.05). Both trypsin and chymotrypsin generated CWPHs had a decrease 
in inhibition activity towards L. monocytogenes with hydrolysis time (P < 0.05). When 
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compared with whey, apart from trypsin hydrolysates (T6), all others showed 
significantly enhanced antimicrobial activity (P < 0.05) against L. monocytogenes. 
 
Table 4: Antimicrobial activity of camel whey protein (W) and camel whey protein 
hydrolysates (CWPHs) produced by pepsin, chymotrypsin and trypsin after 3 and 6 h 
of hydrolysis. Antimicrobial activity is measured in the form of growth inhibition %. 
Data represent mean ± SD (n = 3) from 3 replicates.  
 
Different lowercase letters in the columns indicate significant differences (P < 0.05) 
among the hydrolysates. 
 
For Staphylococcus aureus, highest antimicrobial activity was depicted by 
pepsin derived CWPHs, followed by chymotrypsin and trypsin (P < 0.05). There was 
no significant difference observed within each hydrolysate and its hydrolysis time i.e. 
pepsin hydrolysates at 3 and 6 h had similar inhibition % (~65.0% ± 0.35), as did 
chymotrypsin (~48.93% ± 1.61) and trypsin (13.34% ± 3.88) at both hydrolysis times. 
Hence, the antimicrobial activity against S. aureus did not increase or decrease with 
hydrolysis time (P > 0.05) for all the CWPHs. However, trypsin generated 
Samples Growth inhibition % 
  
Cronobacter 
sakazakii 
Listeria 
monocytogenes 
Staphylococcus 
aureus 
Escherichia 
coli 
Salmonella 
typhimurium 
W 22.42 ± 0.39 a 30.21 ± 9.59 a 7.07 ± 0.35 a 9.42 ± 0.84 a 3.47 ± 0.21 a 
P3 41.98 ± 0.59 c 75.54 ± 0.10 de 64.94 ± 3.40 c 10.55 ± 1.12 a 45.73 ± 4.36 e 
P6 51.59 ± 0.72 d 81.49 ± 2.05 e 65.0 ± 0.35 c 40.41 ± 4.62 c 50.1 ± 1.30 e 
C3 46.72 ± 3.68 cd 65.42 ± 0.10 cd 48.93 ± 1.61 b 19.17 ± 1.19 ab 25.87 ± 4.87 cd 
C6 33.29 ± 0.46 b 52.87 ± 5.58 bc 48.34 ± 3.28 b 17.42 ± 5.46 ab 26.82 ± 5.96 d 
T3 27.49 ± 0.85 a 45.28 ± 4.11 b 6.18 ± 3.04 a 59.41 ± 6.23 d 15.54 ± 5.60 bc 
T6 49.62 ± 3.62 d 29.95 ± 0.05 a 13.34 ± 3.88 a 27.16 ± 1.33 b 5.94 ± 0.21 ab 
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hydrolysates showed antimicrobial activity similar to the intact camel whey proteins 
(W) (P > 0.05). Thus, antimicrobial activity against S. aureus was highest for pepsin 
hydrolysates and lowest for trypsin hydrolysates as well as intact whey proteins.  
For Escherichia coli, trypsin generated hydrolysates showed the highest 
antimicrobial activity after 3 h of hydrolysis (59.41% ± 6.23). In contrast, 
antimicrobial activity of pepsin derived CWPHs at 3 h was the lowest (10.55% ± 1.12). 
Inhibition activity of chymotrypsin generated hydrolysates against E. coli remained 
the same at 3 and 6 h (P > 0.05), while for pepsin hydrolysates, it notably increased 
from 3 to 6 h (P < 0.05). A decrease in growth inhibition % was seen in trypsin derived 
CWPHs after 6 h (P < 0.05). Both intact whey protein and pepsin P3 hydrolysates (3 
h) had no significant difference in their antimicrobial activity (P > 0.05). Overall, 
highest antimicrobial activity against E. coli was demonstrated by trypsin (T3) 
generated hydrolysates while lowest activity was shown by pepsin (P3) hydrolysates.  
 For Salmonella typhymurium, varied antimicrobial activity was observed. 
Pepsin derived hydrolysates after 3 h of hydrolysis showed the highest inhibition % 
(50.1% ± 1.30) with no improvement in antimicrobial activity after 6 h of hydrolysis 
time (P > 0.05). Second best were CWPHs generated from chymotrypsin, which had 
a very slight increase in % inhibition from 3 to 6 h (25.87% ± 4.87 to 26.82% ± 5.96). 
The least antimicrobial activity against S. typhymurium was shown by trypsin derived 
CWPHs after 3 h of hydrolysis (15.54% ± 5.60), which further decreased after 6 h of 
hydrolysis (5.94% ± 0.21) (P < 0.05). In comparison to all the hydrolysates, intact 
whey had the lowest activity (3.47% ± 0.21). Thus, after the hydrolysis process, the 
antimicrobial activity against S. typhymurium was enhanced for all hydrolysates; 
highest for pepsin and lowest for trypsin derived CWPHs. 
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4.4 Antihypertensive Activity of Camel Whey Protein Hydrolysates 
ACE inhibitory activity of camel whey protein hydrolysates (CWPHs) is 
shown in Figure 7. It was observed that the ACE inhibition values (%) displayed by 
camel whey proteins and different hydrolysates varied from 19.4 % to 80.4 %. 
Unhydrolyzed whey had very low ACE inhibition value (19.4% ± 0.15). However, 
upon hydrolysis, the ACE inhibitory values significantly increased for all six CWPHs 
in comparison to intact camel whey proteins (W) (P < 0.05). Among all CWPHs, ACE-
inhibitory activities of the pepsin and chymotrypsin generated hydrolysates after 3h of 
hydrolysis were most efficient in comparison to other hydrolysates (P < 0.05), with 
trypsin (T3) generated hydrolysates depicting the least inhibition. Pepsin (P3) 
generated CWPHs after 3h of hydrolysis displayed highest ACE-inhibition activity 
(80.4% ± 0.23) followed by chymotrypsin (C3) generated CWPHs (67.9% ± 3.67). 
When hydrolysis time increased from 3 to 6 h, the ACE inhibition activity of both 
pepsin and chymotrypsin-generated hydrolysates decreased to 60.26% ± 2.99 and 
51.59 % ± 0.20 respectively (P < 0.05). 
 
 
 
 
 
 
 
 
Figure 7: ACE inhibition activity of camel whey protein (W) and camel whey protein 
hydrolysates (CWPHs) produced by pepsin, chymotrypsin and trypsin after 3 and 6 h 
of hydrolysis. Data represent mean ± SD (n = 3) from 3 replicates. Different 
lowercase letters indicate significant differences (P < 0.05) among different CWPHs. 
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 Trypsin generated hydrolysates, on the other hand, showed an increased 
inhibitory activity from 41.76 % ± 1.85 to 56.66% ± 1.85 when the hydrolysis time 
increased from 3 to 6 h. Overall, pepsin hydrolysates (P3) had the highest inhibition 
activity against ACE enzyme, while trypsin at 3 h had the lowest inhibition value 
among all the hydrolysates.  
4.5 Antidiabetic Activity of Camel Whey Protein Hydrolysates 
4.5.1 DPP-IV Inhibitory Activity  
DPP-IV inhibitory activities demonstrated by CWPHs generated by gastric and 
intestinal enzymes after 3 and 6 h of hydrolysis is shown in Figure 8. The results 
showed that DPP-IV inhibitory activity was significantly enhanced 3 to 4 times after 
hydrolysis (P < 0.05). The inhibition activity for all 3 enzymes did not showed a 
significantly difference with hydrolysis time (P > 0.05), except trypsin generated 
hydrolysates, which increased from 3 to 6 h of hydrolysis time (P < 0.05). 
 
 
 
 
 
 
 
 
Figure 8: DPP-IV inhibition activity of camel whey protein (W) and camel whey 
protein hydrolysates (CWPHs) produced by pepsin, chymotrypsin and trypsin after 3 
and 6 h of hydrolysis. Data represent mean ± SD (n = 3) from 3 replicates. Different 
lowercase letters indicate significant differences (P < 0.05) among different CWPHs.  
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Pepsin generated CWPHs at 3 h had the highest inhibition (93.4% ± 1.61) (P < 0.05), 
while trypsin hydrolysates at 3 h had the lowest (65.31% ± 0.49). After 6 h of 
hydrolysis, DPP-IV inhibition activity of pepsin and trypsin hydrolysates was 
comparable with no significant differences in their activity (89.01% ± 3.84) (P > 0.05). 
Also, chymotrypsin CWPHs activity didn’t show any change with hydrolysis time: 
inhibition at both 3 and 6 h was 81.42% (P > 0.05). The DPP-IV inhibitory activity of 
all CWPHs (65 to 93.4%) was significantly higher when compared to unhydrolyzed 
camel whey (15% ± 3.64) (P < 0.05) demonstrating that the three enzyme hydrolysates 
showed strong DPP-IV inhibitory activity.  
4.5.2 α-Glucosidase Inhibitory Activity 
Figure 9 shows the α-glucosidase inhibition demonstrated by CWPHs 
generated by pepsin, trypsin and chymotrypsin after 3 and 6h of hydrolysis. It was 
observed that the α-glucosidase inhibition activity of whey protein and its hydrolysates 
varied from 24.5 % to 78.6 %. Pepsin (P3) and chymotrypsin (C3) generated CWPHs 
had the highest α-glucosidase inhibition value (78.0%) at 3 h (P > 0.05). Conversely, 
trypsin (T3) produced hydrolysates showed the lowest inhibition activity (24.5% ± 
3.46). At 6 h of hydrolysis time, α-glucosidase inhibitory activity of both pepsin (P6) 
and chymotrypsin (C6) generated hydrolysate decreased with no significant 
differences between them (P > 0.05). On the other hand, tryptic hydrolysates’ 
inhibition activity increased with increase in hydrolysis time from 3 to 6 h (24.5% ± 
3.46 to 38.2% ± 5.27).  
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Figure 9: 𝛼-glucosidase inhibition activity of camel whey protein (W) and camel 
whey protein hydrolysates (CWPHs) produced by pepsin, chymotrypsin and trypsin 
after 3 and 6 h of hydrolysis. Data represent mean ± SD (n = 3) from 3 replicates. 
Different lowercase letters indicate significant differences (P < 0.05) among different 
CWPHs. 
 
When compared to the unhydrolyzed whey protein (44.7% ± 2.13), pepsin and 
chymotrypsin generated hydrolysates showed higher inhibition. However, trypsin (T3) 
derived CWPHs at 3 h had lower activity (24.5% ± 3.46), and similar activity at 6 h (P 
> 0.05) when compared to the intact whey proteins. Overall, pepsin and chymotrypsin 
CWPHs had highest α-glucosidase inhibition activity, whereas trypsin had the lowest.  
4.5.3 α-Amylase Inhibitory Activity 
CWPHs were also explored for their ability to act as an α-amylase inhibitor 
that can retard the starch hydrolysis and production of glucose. Figure 10 shows α-
amylase inhibitory potential of camel whey proteins and CWPHs generated by gastric 
and pancreatic enzymes. 
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Figure 10: α-amylase inhibition activity of camel whey protein (W) and camel whey 
protein hydrolysates (CWPHs) produced by pepsin, chymotrypsin and trypsin after 3 
and 6 h of hydrolysis. Data represent mean ± SD (n = 3) from 3 replicates. Different 
lowercase letters indicate significant differences (P < 0.05) among different CWPHs. 
 
 α-amylase inhibition of the intact whey proteins displayed the least inhibition 
(18.72% ± 3.81) compared to the CWPHs. All hydrolysates from the 3 enzymes 
showed significant higher amylase inhibition activity, which increased with the 
hydrolysis time. Indeed, at 3 h hydrolysis time, peptic CWPHs showed the highest α-
amylase inhibition (52.54% ± 2.72), followed by chymotrypsin (C3) (43.01% ± 5.46) 
and trypsin (T3) generated CWPHs (30.72% ± 4.90) (P < 0.05). After 6 h of hydrolysis 
time, the inhibition activity of chymotrypsin (C6) and pepsin (P6) generated 
hydrolysates increased but was not significantly different among each other (P > 0.05). 
Trypsin (T6) generated CWPHs inhibition activity also increased from 3 to 6 h but 
compared to the other two hydrolysates (P6 and C6), it was the lowest at 6 h (57.45% 
± 5.77) (P < 0.05). Thus, an increase in inhibition activity at 6 h was observed for 
hydrolysates produced from all 3 enzymes. Overall, among the enzymes, hydrolysates 
from chymotrypsin and pepsin at 6 h had highest amylase inhibition activity, while 
trypsin generated hydrolysates at 3 h had the lowest activity.  
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4.6 Anticholesterol Activity of Camel Whey Protein Hydrolysates 
4.6.1 Cholesterol Esterase Inhibition Activity 
 Cholesterol esterase inhibition activity exhibited by CWPHs generated by 
gastric and pancreatic enzymes is shown in Figure 11. When the hydrolysis was carried 
for 3 h, only chymotryptic hydrolysate showed significant higher inhibition activity 
(15.22% ± 0.07), compared to intact camel whey protein (W), peptic hydrolysate 
(3.73% ± 0.05), and trypsin (0.73% ± 0.43) generated (P < 0.05). 
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Figure 11: Cholesterol esterase inhibition activity of camel whey protein (W) and 
camel whey protein hydrolysates (CWPHs) produced by pepsin, chymotrypsin and 
trypsin after 3 and 6 h of hydrolysis. Data represent mean ± SD (n = 3) from 3 
replicates. Different lowercase letters indicate significant differences (P < 0.05) 
among the hydrolysates. 
 
However, after 6 h of hydrolysis time, peptic and tryptic derived CWPHs 
displayed enhanced activity significantly which increased to 21.32% ± 0.34 and 
17.92% ± 0.90, respectively (P < 0.05). Interestingly, chymotrypsin generated 
hydrolysates after 6h of hydrolysis displayed no inhibition of cholesterol esterase at 
all. Compared to control whey (4.3% ± 0.06), peptic hydrolysates at 3 h showed similar 
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cholesterol esterase inhibition activity (3.73% ± 0.05) (P > 0.05), while both 
chymotrypsin (C6) and trypsin (T3) derived hydrolysates showed a significantly lower 
inhibitory activity than intact whey proteins (W) (Figure 11). Overall, highest 
cholesterol-esterase inhibition activity was observed for pepsin CWPHs (P6), trypsin 
(T6) and to less extent chymotrypsin (C3) hydrolysates.  
4.6.2 Lipase Inhibition Activity 
Inhibition of pancreatic lipase activity by camel whey intact proteins and 
CWPHs is shown in Figure 12. Lipase inhibition activity was significantly enhanced 
upon hydrolysis for all hydrolysates when compared to intact camel whey proteins (W) 
(P < 0.05). Peptic hydrolysates (P3) showed highest lipase inhibitory activity (49.76% 
± 4.62) when compared to the other two enzymes. Chymotryptic (C3) (48.35% ± 1.87) 
and tryptic (T3) hydrolysates (34.89% ± 4.23) at 3 h were not far behind the pepsin 
generated CWPHs (P < 0.05). 
 
 
 
 
 
 
Figure 12: Lipase inhibition activity of camel whey protein (W) and camel whey 
protein hydrolysates (CWPHs) produced by pepsin, chymotrypsin and trypsin after 3 
and 6 h of hydrolysis. Data represent mean ± SD (n = 3) from 3 replicates. Different 
lowercase letters indicate significant differences (P < 0.05) among different 
hydrolysates. 
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With an increase in hydrolysis time from 3 to 6 h, pepsin (P6) derived CWPHs 
displayed no significant difference in lipase inhibitory activity (P > 0.05). In contrast, 
decrease in inhibition activity was seen for the chymotrypsin (C6) and trypsin (T6) 
generated hydrolysates at 6 h (P > 0.05). Overall, all the hydrolysates exerted a higher 
lipase inhibitory activity in contrast to intact whey which demonstrated 15.33% ± 2.98 
inhibition of lipase activity. Thus, among the hydrolysates, pepsin (both P3 and P6) 
and trypsin (T6) derived CWPHs had the highest and lowest lipase inhibitory activity, 
respectively. 
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Chapter 5: Discussion 
 
5.1 Characterization of Camel Whey Protein Hydrolysates 
Application of protein hydrolysates in new food product development requires 
prior characterization of the hydrolysates produced. One way to characterize 
hydrolysates is through degree of hydrolysis (DH) which calculates the percentage of 
peptide bond breakdown in the native protein (Wang & Wang, 2001). This breakdown 
or hydrolysis process is the key way in which major proteins are degraded to release 
small peptides and free amino acids which are known to contribute in enhancing the 
functional and bioactive properties of food proteins (Cheison et al., 2009; Le Maux et 
al., 2016). Thus, DH is an important parameter which explains the effects and the 
scope of protein hydrolysis (Cheison et al., 2009).  
The enzymatic hydrolysis of camel whey protein by all 3 enzymes, in general, 
depicted an increase in DH with hydrolysis time (Figure 1). Chymotrypsin-generated 
hydrolysates had the highest DH after 6h, suggesting that in comparison to other 
enzymes, chymotrypsin enzyme was more efficient in its proteolytic activity. Similar 
results were reported by Salami et al. (2008) where camel milk casein was more 
susceptible to chymotrypsin hydrolysis than bovine casein.  
The differences in DH (%) among the hydrolysates produced could be 
attributed to enzyme reaction rate, enzyme specificity and substrate affinity (Dryakova 
et al., 2010). Consequently, the amino acid sequence of the resultant hydrolysates 
would also be different, since all 3 enzymes cleave at different sites - chymotrypsin 
cleaves peptide bond next to aromatic amino acids like Phe, Tyr, Trp (López-Fandiño 
et al., 2006), trypsin acts at carboxyl side of amino acids arginine or lysine, while 
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pepsin prefers aromatic residues (Tavano, 2013). Moreover, the extent of DH value 
reflects the content of shorter peptides liberated -  higher the DH, higher is the content 
of released amino groups or shorter peptides liberated (Morais et al., 2005).  
A kinetic characterization study revealed that caseins are more readily 
hydrolyzed than whey counterparts due to their open tertiary structure, more flexibility 
and presence of prolyl residues (Damodaran 1994; Qi et al., 2003; Mizuno et al., 2004 
as cited in Salami et al., 2008). On the other hand, whey protein’s compact and 
globular structure makes it less susceptible to digestion. For this reason, whey protein’s 
enzymatic hydrolysis was carried out for a longer time (6 h) to achieve maximum 
degradation (Salami et al., 2008). Thus, in the present study, although a low DH at 3 
h for whey hydrolysates was seen, further hydrolysis produced a greater DH (%) for 
all three enzymes (Figure 1).  
Another way to characterize and monitor the production of shorter peptides 
(usually represented as short peaks) from milk proteins is RP-HPLC which was 
performed in the present study (Figure 2). Since RP-HPLC works on the principle of 
separation of molecules based on hydrophobicity, hydrophobic molecules in the polar 
mobile phase tend to adsorb to the stationary phase, while hydrophilic molecules in 
the mobile phase pass through the column and are eluted first (Wall et al., 2000; 
Sharma, 2014). This indicates that chymotrypsin and pepsin generated hydrolysates 
possessed higher hydrophilic peptides as compared to trypsin, since their elution was 
earlier to that of trypsin generated hydrolysates. Also, chymotrypsin derived 
hydrolysates had the highest detector response for the short peptide peaks, followed 
by pepsin and trypsin hydrolysates. which supports our DH (%) results where 
chymotrypsin (C6) hydrolysates displayed highest DH (%) (Figure 1).  
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Prior to hydrolysis, camel whey protein contained α-LA as the major protein, 
as indicated by a single sharp peak (Figure 2). Indeed α-LA is the major protein in 
camel whey as reported in many studies (Farah, 1986; Farah & Atkins, 1992; Laleye 
et al., 2008; Berhe et al., 2017). Upon hydrolysis, none of the six hydrolysates showed 
a prominent peak of α-LA which suggests that almost complete degradation of α-LA 
was carried out by the enzymes. Hence, all three digestive enzymes were efficient in 
breaking down the camel whey protein and producing shorter peptides at different 
degrees. 
5.2 Antioxidant Activity 
The mechanisms through which peptides in the protein hydrolysates show their 
antioxidant activity is by radical-scavenging, reducing power, inhibition of lipid 
peroxides, chelation of metal ions, or a combination of these (Sarmadi & Ismail, 2010). 
Thus, it is necessary to substantiate the antioxidant capacity of the bioactive 
compounds by examining them through different antioxidant assays, since the 
mechanism of action is different in different assays (Alam et al., 2013). For this reason, 
four in vitro test procedures were carried out to evaluate the antioxidant activities of 
camel whey protein hydrolysates.  
An example of a free radical is DPPH, whose scavenging activity indicates the 
antioxidant potential of a compound (Power et al., 2013). Camel whey protein and its 
hydrolysates were tested for their DPPH radical scavenging activity (Figure 3). It was 
observed that chymotrypsin generated CWPHs were most efficient at scavenging 
DPPH radicals, thus having a positive relationship between hydrolysis time and DPPH 
activity (Kumar et al., 2016a). Similar results were reported by Salami et al. (2010) 
where chymotrypsin derived bovine and camel whey protein hydrolysates displayed 
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higher radical scavenging activity compared to tryptic hydrolysates. It is known that 
chymotrypsin enzyme favors cleavage at carboxylic side of aromatic side chains and 
produces peptides with amino acids at C-terminal position having antioxidant potential 
(Pihlanto, 2006). Hence, the results of present study as well as previous reports suggest 
that for peptides to show good antioxidant properties, amino acids at C-terminal 
residues have a critical role in showing antioxidant potential. Similarly, Conway et al. 
(2012) proposed that peptides originating from major whey proteins (α-LA and β-LG) 
were likely responsible for the antioxidant activity. The antioxidant activity arises due 
to specific amino acid residues present in the peptides, either because of their 
capacities to donate protons to free radicals (Trp, Phe, Tyr, His, and Cys) or because 
of their capacities to chelate metal cations (Glu, Asp, Lys, Arg, and His) (Elias et al., 
2006). 
 Trypsin-treated hydrolysates after 6 h showed a decrease in radical scavenging 
activity. Furthermore, hydrolysates from pepsin performed poorly as they had the 
lowest antioxidant activity compared to other two enzyme generated CWPHs as well 
as intact whey. A recent study by Abd El-Fattah et al. (2017) also reported low DPPH 
scavenging activity for trypsin treated bovine milk. The reason could be that structural 
conformation of the peptide or the peptide bond itself could have decreased the 
antioxidant activity. Since the sequence of amino acids in the hydrolysates is 
dependent on the specificity of the protease, the lower activity of pepsin and trypsin 
hydrolysates may have been due to the enzymes activity and peptides generated thereof 
(Hernández-Ledesma et al., 2005). Hence, results of the present study agree that both 
pepsin and trypsin generated CWPHs didn’t have strong antioxidant potential due to 
reasons mentioned above. 
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 On the other hand, unhydrolyzed camel whey protein also displayed good 
antioxidant activity. It has been suggested that both hydrolyzed and unhydrolyzed 
camel milk proteins possess the ability to donate free electrons which interact with free 
radicals, form stable molecules and stop the radical chain reaction (Kumar et al., 
2016a). Similar results were reported by Al Shamsi et al. (2018) where even native 
camel milk protein displayed scavenging activity of DPPH radicals. Due to the 
presence of certain amino acid residues like Phe, Trp, His, Tyr and Cys, the milk 
proteins are capable of donating protons to free radicals, thus showing antioxidant 
activity (Elias et al., 2008). Therefore, in the present study, camel whey protein 
demonstrated some degree of antioxidant activity and upon hydrolysis, especially with 
chymotrypsin, resulted in a six-fold increase in the DPPH radical scavenging activity.  
ABTS was another free radical whose potential scavenging activity by 
hydrolyzed and unhydrolyzed camel whey protein was measured (Figure 4). All 
hydrolysates showed an increase in ABTS radical scavenging activity with progression 
of hydrolysis time. Highest ABTS radical scavenging activity was demonstrated by 
chymotrypsin treated hydrolysates, followed by trypsin- and pepsin-treated 
hydrolysates. Kumar et al. (2016a) recorded increased scavenging activity of α-
chymotrypsin samples (P < 0.05), which was higher than alcalase and papain 
hydrolysates. Kumar et al. (2016b) also reported similar results in their study of camel 
casein hydrolysates. In addition, Salami et al. (2011) found that α-chymotrypsin 
generated hydrolysates from camel whole casein had higher antioxidant activity than 
pepsin and trypsin peptide fractions. They deduced that the C-terminal amino acids are 
important in determining the antioxidant activity of a peptide fraction. Thus, results of 
the present study are in accordance with the previous literature. The differences in the 
antioxidative activity between the hydrolysates could be due to various factors like 
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amino acid position, accessibility (Elias et al., 2005, 2008), sequence and presence of 
hydrophobic/aromatic amino acids (Salami et al., 2011). Overall, our results revealed 
that free radical scavenging activity of CWPHs improved significantly after 
hydrolysis. 
 The third assay performed was the ferric reducing antioxidant power (FRAP) 
assay which determines the reducing ability of an antioxidant from the ferric ion, ferric 
2,4,6-tripyridyl-s-triazine complex [Fe(III)-(TPTZ)2]3+ to the blue colored [Fe(II)-
(TPTZ)2]2+ ferrous complex by donating an electron (Benzie & Strain 1996). The 
reducing power of a compound can be used to assess its antioxidant activity potential 
(Huang et al., 2004). The FRAP values of trypsin (T3, T6) and chymotrypsin (C6) 
hydrolysates were less than that of intact camel whey proteins (Figure 5). Also, there 
was no significant difference between FRAP values of intact camel whey protein and 
chymotrypsin derived hydrolysates (C3) (P > 0.05). This was similar to results 
obtained by Al-Shamsi et al. (2018) where unhydrolyzed camel whey had higher 
FRAP values than hydrolysates produced by alcalase, papain and trypsin. Two 
parameters play a vital role in determining the reducing power of protein hydrolysates: 
(i) varying degree of hydrolysis, and (ii) enzymes used (Klompong et al., 2007). It is 
possible that the differences in degree of hydrolysis produced peptides not capable of 
reducing ferric iron (III) to ferrous iron (II). This could be why the hydrolysis process 
didn’t have a significant effect on the reducing power of the CWPHs (Figure 5). 
Furthermore, since the reducing power is directly correlated with peptide cleavages 
(Cumby et al., 2008), it could be that trypsin and chymotrypsin enzyme specificity had 
very less influence on enhancing the reducing power of the hydrolysates in the present 
study.  
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Our results show that the reducing power of pepsin generated hydrolysates was 
somewhat improved in comparison to intact whey proteins (P < 0.05), but the FRAP 
value was not greatly enhanced after hydrolysis. Thus, the resultant CWPHs from 
pepsin showed marginal reducing power while those from trypsin and chymotrypsin 
were not efficient at donating electrons. 
Chelating activity is another important antioxidant potential in which the tested 
compound demonstrates the capacity to chelate transition metal ions. Ferrous ions are 
a type of metal ions that have been associated with cellular oxidative damage leading 
to lipid peroxidation (Huang et al., 2002). Pepsin and chymotrypsin generated CWPHs 
displayed similar chelating activity after 3 h of hydrolysis (P > 0.05), but at 6 h, activity 
of peptic hydrolysates reduced (Figure 6). This reduction has been hypothesized to be 
due to decreased peptide chain length, particularly at longer hydrolysis time. The study 
by Je et al. (2009) on tuna liver protein and another study on sodium caseinate 
hydrolysate (Luo et al., 2014) also reported a similar phenomenon where chelating 
activities of hydrolysates produced at longer hydrolysis time decreased slightly. In 
contrast, the chelating activity of trypsin generated hydrolysates after 6 h significantly 
increased. It could be that trypsin mediated peptide cleavage caused a more 
pronounced metal ion binding due to increased concentration of carboxylic groups in 
the acidic and basic amino acid branches (Abd El-Fattah et al., 2017).  
CWPHs produced by different enzymes displayed varied efficiency in 
chelating iron. The differences in chelating activity has also been reported by Conway 
et al. (2012) where whey concentrate’s sequential hydrolysis with pepsin and trypsin 
displayed different levels of iron chelation. In the present study, chymotrypsin and 
pepsin displayed higher degree of hydrolysis (Figure 1) but lower Fe2+ iron chelation 
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activity compared to trypsin (Figure 6), suggesting that shorter peptides generated by 
higher DH might lose their ability to complex with Fe2+ and chelate Fe2+. 
  Intact camel whey had the lowest activity in comparison to other samples, and 
the activity was enhanced only after hydrolysis. The results can safely suggest that the 
inactive peptide fragments trapped in the whey protein were released following 
enzymatic hydrolysis and thus, improved the iron chelating activity of the camel whey 
protein. Overall, the antioxidant activity status of CWPHs evaluated by different 
methods shows that the extent of hydrolysis and the type of enzymes used are two 
important factors that govern the release of encrypted inactive antioxidant peptide 
sequences from the intact whey proteins. 
5.3 Antimicrobial Activity 
Antimicrobial activity of bioactive peptides is displayed by various 
mechanisms such as prebiotic effect, peptides that are able to block attachment or 
invasion of pathogen microorganism, or peptides that could induce a killing or 
inhibiting effect on the growth of microorganism (Hernández-Ledesma et al., 2014). 
Milk-derived antimicrobial peptides contain highly positive charged sequence. Thus, 
the net positive charge may help in binding of the peptides to negatively charged 
bacterial membranes. Also, the amphiphilic nature of peptides aids in bacterial 
membrane disruption (Hernández-Ledesma et al., 2014).  
To measure the antimicrobial efficacy of the camel whey protein and its 
hydrolysates, growth inhibition (%) of 5 pathogenic bacteria - two Gram-positive 
bacteria (L. monocytogenes, S. aureus) and three Gram-negative bacteria (E. coli, S. 
typhymurium, C. sakazakii) was observed and values were recorded in Table 4.  
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Overall, both intact camel whey proteins and hydrolyzed camel whey proteins 
were capable of inhibiting growth of most of the pathogenic bacteria in this study. 
Particularly, intact camel whey protein showed antimicrobial activity that was not 
significantly different from the hydrolysates produced from trypsin (against C. 
sakazakii, L. monocytogenes and S. aureus) and pepsin (against E. coli). Although the 
activities were not very high, inhibition was still observed for intact whey protein 
indicating that antimicrobial factors like lactoferrin, lysozyme, and immunoglobulins 
naturally present in camel whey displayed effective antimicrobial activity (Salami et 
al., 2010). This was also observed in a study by Jrad et al. (2014b) where camel milk 
whey protein exhibited a greater growth-reducing effect on E. coli than bovine whey 
protein. Subsequent treatment of camel whey proteins with proteases like trypsin, 
chymotrypsin and proteinase K gave hydrolysates with three-fold increase in their 
antibacterial activities (Salami et al., 2010). In the present study too, enhanced 
antimicrobial activities is shown for nearly all CWPHs derived from pepsin, trypsin 
and chymotrypsin when compared to non-hydrolyzed whey protein.  
 
Both pepsin and trypsin hydrolysates against C. sakazakii had a higher 
inhibition activity at 6 h, while activity against C. sakazakii displayed by chymotrypsin 
generated CWPHs decreased at the same time. L. monocytogenes, an important 
pathogenic bacterium that is found in contaminated raw and processed meat products, 
was also inhibited by the CWPHs. Pepsin generated hydrolysates showed highest and 
increased activity with hydrolysis time, whereas for other two enzymes, inhibition 
activity decreased at 6 h. S. aureus was the only bacteria against which hydrolysates 
showed improved antimicrobial activity than intact whey, but with no significant 
increase or decrease in their activity from 3 to 6 h of hydrolysis. Growth inhibition (%) 
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of E. coli and S. typhimuriumwas found to be highest by trypsin (T3) and pepsin (P3, 
P6) derived CWPHs, respectively (Table 4).  
Overall, amongst the enzymes, peptic hydrolysates were the best in displaying 
antimicrobial activity by displaying growth inhibition (%) ranging from 10.55% ± 1.12 
to 81.49% ± 2.05 against most bacteria. No set pattern between inhibition activity and 
hydrolysis time was observed for tryptic and chymotryptic hydrolysates against the 
five bacteria tested. 
The differences in antimicrobial activity of hydrolysates produced with 
different enzymes could be attributed to differences in the concentration, size and ionic 
nature of pepides generated (Kumar et al., 2016b). Moreover, the efficacy of 
antimicrobial activity relies on many factors like hydrophobicity (Kustanovich et al., 
2002), structural diversity (Gennaro & Zanetti, 2000), and presence of certain amino 
acid residues like Arg, Pro, Cys, Gly, His (Andreu & Rivas, 1998). Synergistic effects 
of different sized and charged peptides may be another reason for high antimicrobial 
activity (Gobbetti et al., 2004). Overall, camel whey protein hydrolysates generated 
with different enzymes displayed varied antimicrobial activities against different 
pathogenic bacteria tested. 
5.4 Antihypertensive Activity 
ACE enzyme converts angiotensin I to angiotensin II, and increases the blood 
pressure (Coates, 2003). Since hypertension is one of the many risk factors for 
cardiovascular diseases, inhibiting ACE to control blood pressure is important. 
Antihypertensive action of bioactive peptides can be due to competitive and/or non-
competitive inhibition of ACE. Competitive inhibition is competition of peptides with 
ACE substrate for the enzyme active sites (Sato et al., 2002). Non-competitive (Leu-
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Trp, Ile-Tyr) and uncompetitive (Ile-Trp, Phe-Tyr) peptides are characterized by 
peptides binding to other enzyme sites which changes enzyme conformation and 
decreases activity. Thus, the interaction between peptides and ACE is greatly 
influenced by a single amino acid substitution as well as isomers (Sato et al., 2002). 
For this, structure-activity studies are vital to understand more (Udenigwe & Aluko, 
2012). Other possible mechanisms of action include increase in activity of some 
vasodilating agents like endothelial NOS, inhibition of renin (by mixed-type inhibition 
mode), induction of vasodilation and reducing the activity of sympathetic system 
(Aluko, 2015)  
 In the present study, intact camel whey’s ACE inhibition activity was 19.4% 
(Figure 7). Previous studies have also reported very low ACE-inhibitory activity of 
non-hydrolyzed bovine β-LG (<10%) (Mullally et al., 1997), and non-hydrolyzed 
sheep cheese whey (12%) (Corrêa et al., 2014). This indicates that intact camel whey 
proteins possessed higher ACE-inhibition activity when compared to whey proteins 
from other species.  
Figure 7 demonstrates very low ACE inhibition activity for native camel whey 
proteins, but higher inhibition activity for the hydrolysates (42-80%). It can be 
suggested that hydrolysis of inactive camel whey protein may release peptides with 
potential ACE inhibitory activities. Similarly, camel whey hydrolysates produced by 
pancreatic enzymes were reported to possess ACE-inhibitory activity. 
Antihypertensive tripeptide isoleucine-proline-proline (IPP) was identified and 
quantified in digested camel milk (Tagliazucchi et al., 2016). Salami et al. (2011) 
noted an increase in ACE inhibitory activities of camel whole casein and camel β-
casein upon hydrolysis by trypsin and chymotrypsin. Tsuda and Miyamoto (2008) also 
reported ACE inhibition activity of a purified peptide from fermented camel milk.  
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Bovine whey studies have depicted similar results. Two highly potent ACE-inhibitory 
peptides corresponding to α-LA and β-LG were identified from bovine whey protein 
concentrate upon hydrolysis (Tavares et al., 2011). β-LG intact protein also 
demonstrated very high ACE-inhibitory activity (73-90%) upon hydrolysis with 
pepsin, trypsin, chymotrypsin and other proteases (Mullally et al., 1997), Proline, 
tryptophan or tyrosine residues in the carboxyl terminal of the protein or peptide are 
commonly associated with ACE-inhibition. When located at the C-terminal position, 
proline has been recognized to be one of the most beneficial residues for peptide 
binding to ACE’s active site. In the present study, the higher ACE inhibitory activity 
was shown by pepsin generated CWPHs (Figure 7). Since pepsin is specific to 
hydrophobic amino acids and α-LA contains a high amount of aromatic amino acid 
residues in the C-terminal position, this would then assist the easy binding to ACE 
(Otte et al., 2007). Therefore, it can be suggested that whey protein hydrolysates from 
pepsin generated most potent ACE-inhibitory hydrolysates.  
5.5 Antidiabetic Activity 
Population studies have shown that consumption of camel milk was correlated 
with low incidence of diabetes in Rajasthan (Agrawal et al., 2004a, 2005b). This was 
attributed to a high content of lactoferrin, immunoglobulin, lactoperoxidase and 
peptidoglycan in camel milk. It has been hypothesized that insulin-like protein in 
camel milk helps maintain insulin secretory activity in pancreatic cells (Shori, 2015). 
A recent cellular study by Abdulrahman et al. (2016) demonstrated camel milk’s 
allosteric effect on human insulin receptor cells, which could have implications on the 
hypoglycemic activity of camel milk, although further investigations at molecular 
levels were recommended to confirm the findings. Other studies showing 
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hypoglycemic activity of camel milk were performed on rats (Agrawal et al., 2004b, 
2005a; Kamal et al., 2007), rabbits (El-Said et al., 2010) and dogs (Sboui et al., 2010a, 
2010b).  
Blood glucose regulation by bioactive peptides is mediated through different 
mechanisms like insulinotropic activity, increased insulin secretion, effect on 
metabolic enzymes involved in serum glucose modulation like DPP-IV, α-amylase, 
and α-glucosidase (Lacroix & Li-Chan, 2014b). Insulinotropic effect is thought to be 
due to the combination of bioactive peptides and branched chain amino acids 
(Luhovyy et al., 2007; Morifuji et al., 2010). The free amino acids are reported to act 
on pancreatic beta cells and promote insulin secretion by membrane depolarization, 
mitochondrial signaling affecting insulin secretion etc. (Newsholme et al., 2010). 
A serine exopeptidase, DPP-IV works by degrading and inactivating hormones 
glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide 
(GIP). These hormones are released upon food ingestion and increase insulin secretion. 
By inhibiting DPP-IV, glycemic regulation in Type 2 diabetes can be improved 
(Nongonierma & FitzGerald, 2017a). Inhibitors of the enzyme dipeptidyl-peptidase IV 
(DPP-IV) are among the newest glucose-lowering drugs available in the market for 
type 2 diabetes patients (Craddy et al., 2014). Apart from such synthetic drugs, some 
studies have reported dietary proteins like milk, egg (Nongonierma & FitzGerald, 
2014a) and fish (Huang et al., 2012) having peptide sequences that may inhibit DPP-
IV enzyme and could potentially complement drug therapy in regulating blood glucose 
levels (Lacroix & Li-Chan 2012b, 2014b, 2016). Despite the knowledge that DPP-IV 
inhibitory peptides can potentially be generated from various food proteins, only one 
recent study has demonstrated DPP-IV inhibitory potential of camel milk protein 
hydrolysates (Nongonierma et al., 2017c), while none have been performed on camel 
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whey protein hydrolysates. In a recent study, camel milk protein tryptic hydrolysates 
were reported to inhibit DPP-IV (Nongonierma et al., 2017c).  
Our results suggested peptic hydrolysates to be the best DPP-IV inhibitors 
(Figure 8). This was similar to in vitro simulated gastrointestinal digestion of whey 
protein isolate by pepsin (78% of DPP-IV inhibition) in a study by Lacroix and Li-
Chan (2013). A different study by Silveira et al. (2013) obtained a hydrolysate from 
tryptic digestion of bovine whey protein concentrate which inhibited DPP-IV activity 
(IC50 value of 1.51 mg/mL).  In the present study, all three enzymes showed more than 
50% inhibition which indicates that the enzymes released potent DPP-IV inhibitors. 
Furthermore, enzyme specificity influences the DPP-IV inhibitory activity of the 
produced hydrolysates (Brandelli et al., 2015). Lacroix et al.  (2016) have reported 
that bovine whey derived protein hydrolysates produced by Thermoase, Peptidase R 
and ProteAX were able to inhibit ACE as well as DPP-IV enzymes at different degrees 
of inhibition. Those hydrolysates which showed highest ACE-inhibitory activity did 
not necessarily display higher DPP-IV inhibitory activity, indicating that active 
peptides responsible for ACE and DPP-IV inhibitory activity might not be the same.  
Studies show that peptides having proline or hydrophobic residues in their 
sequence usually identify as DPP IV inhibitors (Lacroix & Li-Chan, 2012b). Also, 
small size and hydrophobicity of these peptides may help in intestinal absorption and 
display of their bioactivity (Nongonierma & FitzGerald, 2014b). The present study on 
camel whey proteins hydrolysates and previous studies on bovine whey protein 
hydrolysates demonstrate that gastric and intestinal enzymes like pepsin, 
chymotrypsin and trypsin are the potential enzymes to generate hydrolysates with 
potent DPP-IV inhibitory activities. This further indicates that camel whey proteins 
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will most likely possess antidiabetic effect after gastric and intestinal digestion upon 
consumption. 
Another way to control type 2 diabetes is through inhibition of α-glucosidase. 
This enzyme is responsible for digesting complex carbohydrates to simpler sugars and 
thus increasing postprandial hyperglycemia (Kahn et al., 2014). It has been proposed 
that peptides act as competitive inhibitors by binding to α-glucosidase enzyme’s active 
site through hydrophobic interactions, thus retarding the absorption of glucose and 
subsequently lowering the insulin levels (Bharatham et al., 2008; Patil et al., 2015).  
 This study presents for the first time the inhibitory potential of whey protein 
hydrolysates towards α-glucosidase & α-amylase. Peptic (P3) and chymotryptic (C3) 
hydrolysates at 3 h showed highest inhibition activity (Figure 9). A study by Lacroix 
and Li-Chan (2013) reported that peptic hydrolysates of bovine whey protein isolate, 
β-LG, and α-LA, at 2.5 mg/mL were able to inhibit α-glucosidase by 36, 33, and 24%, 
respectively, whereas the non-hydrolyzed counterparts did not display any enzyme 
inhibition. In comparison, the peptic hydrolysates in the present study showed 
markedly high inhibition activity. These differences in the values could be because the 
previous study used α-glucosidase from mammalian (rat) intestine while our source of 
the enzyme was from baker’s yeast. It has been reported that the extent of α-
glucosidase inhibition greatly depends on the origin of enzyme. The structural 
differences of the enzymes and their consequent altered binding sites could be a reason 
for the variation in inhibition values (Oki et al., 1999; Kim et al., 2011) 
It was also reported by Lacroix and Li-Chan (2013) that non-hydrolyzed 
protein was not able to inhibit α-glucosidase enzyme. However, the native whey 
protein in our study showed 45% inhibition. Findings from several studies on camel 
72 
 
 
 
 
whey protein supplementation showed restoration of oxidative stress levels and 
lowered blood insulin levels in diabetic rats (Ebaid et al., 2013), improvement of 
wound healing in STZ-induced diabetic mouse model (Badr, 2013), and treatment of 
immune impairment in type 1 diabetes rat model (Ebaid, 2014). Also, camel milk whey 
protein is reported to be rich in half-cystine which is found to be superficially similar 
to the peptides of insulin family (Beg et al., 1986). Hence, our results of camel whey 
protein inhibiting α-glucosidase agree with previous studies.  Trypsin derived 
hydrolysates were not efficient at inhibiting α-glucosidase enzyme. It may be due to 
the protein hydrolysates consisting of a mixture of peptides, and only some of these 
peptides can show good activity. Thus, to achieve high potency, isolated peptides 
would naturally be a better choice (Lacroix & Li-Chan, 2013). Since inhibition of α-
glucosidase is considered to be an effective strategy for the control of diabetes, the 
results of the present study indicate that CWPHs which exhibit inhibitory activity up 
to 78% towards α-glucosidase could be considered as potential antidiabetic agents 
The third experiment carried out to explore indication of anti-diabetic effect of 
CWPHs was α-amylase inhibition. This enzyme hydrolyses α-glycosidic bond on 
polysaccharide such as glycogen and starch to produce glucose and maltose. α-amylase 
activity inhibitors block dietary starch from being absorbed in the body causing 
delayed digestion of carbohydrates, thus reducing glucose absorption rate and 
postprandial blood glucose levels (Vankudre et al., 2015).  
In general, hydrolysates from camel whey protein showed enhanced amylase 
inhibition activity than intact whey proteins (Figure 10). Shori and Baba (2014) 
reported a higher amylase inhibition activity (P < 0.05) in Allium sativum enriched 
camel milk yogurt compared to bovine milk yogurt. Our results also concur that 
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hydrolysis of camel whey protein releases peptide fragments that can inhibit amylase 
enzyme. The inhibition is more potent when hydrolysis time is prolonged (Figure 10). 
No study has previously reported α-amylase inhibitory properties of whey proteins and 
their hydrolysates. Proteins from other than milk have been explored for α-amylase 
inhibition. Pinto bean protein hydrolysates generated by protomex were reported to 
have α-amylase inhibition activity (15.78 ± 1.70 to 52.08 ± 2.37 %) (Ngoh & Gan, 
2016). Yu et al. (2012) studied the hydrolysis of egg albumin with alcalase, where 
enhanced α-amylase inhibitory activity was displayed with IC50 value of 120 ± 4.0 and 
110 ± 6.2 µmol l-1 for identified peptides KLPGF and EAGVD, respectively Thus, 
CWPHs generated by the 3 enzymes in the present study showed an increased amylase 
inhibition activity with increase in hydrolysis time. From the results of all three 
inhibition tests, it can be suggested that hydrolysates from camel whey protein 
demonstrated significant anti-diabetic effects.  Thus, camel whey derived bioactive 
peptides may help in glycemic management strategy, although further work is needed 
to fully determine the bioavailability of the peptides in humans.  
5.6 Anticholesterol Activity 
An important risk factor in the pathogenesis of cardiovascular diseases, 
particularly atherosclerosis, is hypercholesterolemia (Grundy et al., 1998). Bioactive 
peptides have been demonstrated to decrease the levels of cholesterol. For instance, 
Nagaoka et al. (2001) in their murine and Caco-2 cells study identified novel 
hypocholesterolemic peptide lactostatin (Ile-Ile-Ala-Glu-Lys) from bovine β-LG 
following trypsin hydrolysis. The results showed inhibition of micellar cholesterol 
solubility, decreased cholesterol absorption and lower serum and liver cholesterol 
levels in rats. Another study investigated β-lactotensin, a peptide isolated from bovine 
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β-LG via chymotrypsin digestion (Yamauchi et al., 2003). They suggested that this 
peptide stimulates bile acid secretion in rats, because of which hypocholesterolemic 
activity was induced.  
Camel milk is considered as a hypolipidemic agent, particularly in diabetic rat 
models due to the presence of insulin-like protein and zinc that decrease the levels of 
triglycerides (Agrawal et al., 2004b; Al Numair, 2010; Zuberu et al., 2017). Elayan et 
al. (2010) found hypocholesterolemic effect of fermented camel milk (gariss) in diet- 
induced hypercholesterolemic rats. They reported that supplementation of 0.5 g for 6 
weeks reduced the level of plasma total cholesterol, LDL-c and triglyceride with no 
significant effect on HDL-c. The mechanism of milk derived hydrolysates showing 
hypocholesterolemic activity is not well understood, but it is speculated that the 
interaction between cholesterol and bioactive peptides leads to a decrease in 
cholesterol levels (Li & Papadopoulos, 1998) 
Our results agree with previous literature that native camel milk whey proteins 
exhibited slight cholesterol-esterase inhibition (Figure 11). This means that camel 
whey protein itself has antilipidemic effects. Hydrolysates derived from pepsin and 
trypsin at 3 h had lower inhibition activity compared to intact whey proteins. However, 
upon further hydrolysis, there was a sharp increase in cholesterol esterase inhibition 
activity in peptic and tryptic hydrolysates. It might be because pepsin and trypsin 
enzymes needed a longer hydrolysis time to expose the hypocholesterolemic peptide 
fragments. On the contrary, chymotrypsin generated hydrolysates showed good 
inhibition initially at 3 h of hydrolysis time, but longer hydrolysis time (6 h) gave 
inhibition activity which was not detectable. It could be that extensive hydrolysis led 
to production of even shorter peptides in chymotrypsin hydrolysates that were unable 
to show their inhibition activity.  
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An important pancreatic enzyme is lipase which helps breakdown triglycerides 
to di- and monoglycerides and into free fatty acids to be absorbed by enterocytes 
(Mukherjee, 2003). Inhibition of pancreatic lipase reduces the efficiency of fat 
absorption in the small intestine and thereby initiates modest long-term reduction in 
body weight (Birari & Bhutani, 2007). Several anti-obesity agents derived from plant 
phytochemicals have been identified for their potential to inhibit lipase activity (Nehir 
& Simsek, 2012).  
The effect of camel whey protein hydrolysates on porcine pancreatic lipase was 
investigated in vitro for the first time in this study. As shown in Figure 12, all 
hydrolysates showed a significant improvement in their lipase inhibitory activity 
compared to the intact whey proteins. In a study conducted on Wistar rats, fermented 
sardinelle protein hydrolysates (FSPHs) produced by proteolytic bacteria were orally 
administered and found to reduce total cholesterol, triglycerides, and LDL-c serum 
levels, increase in HDL-c and decrease pancreatic lipase activity (Jemil et al., 2017). 
The authors concluded that FSPHs possessed bioactive peptides that could attenuate 
hyperlipidemia and protect against cardiovascular disease in rats fed a high caloric 
diet. Another study examined synthetic polypeptides of apolipoprotein C-III (apoC-
III) and their effects on lipoprotein lipase inhibitory activity. Around 79% inhibition 
of lipoprotein lipase was observed (McConathy et al., 1992). Results from this study 
were similar in the manner that the peptides produced by enzymatic hydrolysis indeed 
showed an enhanced lipase inhibitory effect; particularly efficient were the peptic 
hydrolysates (Figure 12). An exceedingly small number of studies have investigated 
the lipase inhibitory potential of milk bioactive peptides, thus more work needs to be 
done to elucidate on the lipase inhibitory effects of such peptides. Overall, both 
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cholesterol esterase and lipase inhibition activity were higher for CWPHs than 
unhydrolyzed whey.   
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Chapter 6: Conclusion 
 
Camel milk as a source of bioactive peptides has gained interest in recent years. 
It’s compositional and nutritional differences to that of bovine or caprine milk makes 
camel milk a good candidate that can be investigated for potential additional benefits. 
Although peptides with biological activities derived from camel milk and camel casein 
protein have been reported previously (Salami et al., 2011; Badr, 2013; Jrad et al., 
2014a, 2014b; Kumar et al., 2016a; Tagliazucchi et al., 2016), there is a lack of data 
available on camel milk whey proteins. Hence, the present study focused on producing 
hydrolysates from camel whey protein using three digestive enzymes – pepsin, trypsin 
and chymotrypsin, and assessing their potential bioactivities in vitro.  
The results from this thesis clearly demonstrated that the camel whey proteins, 
upon digestion with gastric (pepsin) and pancreatic (trypsin and chymotrypsin) 
enzymes, exert potential antioxidative and antimicrobial effects, with chymotryptic 
hydrolysates showing highest DPPH and ABTS radical scavenging activity, and peptic 
hydrolysates displaying significant pathogen growth inhibition (%) activity, 
respectively. ACE inhibitory properties were drastically increased upon hydrolysis 
with all three enzymes, pepsin displaying a 4-fold increase. Anti-cholesterol activities 
were demonstrated for the first time by the CWPHs wherein pepsin (6 h) generated 
hydrolysates displayed highest lipase and cholesterol esterase inhibition activities. 
Moreover, CWPHs inhibited enzymes like DPP-IV, α-glucosidase and α-amylase 
which suggests potential anti-diabetic activities of camel milk whey proteins. Lastly, 
the present study suggests that hydrolysis time may affect bioactivity of the 
hydrolysates. In some experiments, longer hydrolysis improved the bioactivity, while 
for some hydrolysates, the opposite was observed. This could be due to enzyme 
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specificity, substrate degradation, and type of amino acid residues being released as 
reported in earlier studies (Otte et al., 2007; Lacroix & Li-Chan., 2013; Kumar et al., 
2016b; Abd El-Fattah et al., 2017; Al-Shamsi et al., 2018).  Overall, while intact camel 
milk whey protein has already been identified for its in vivo therapeutic properties 
owing to its content of lactoferrin, immunoglobulin and other active proteins, camel 
milk whey proteins upon hydrolysis may exhibit multifunctional bioactive properties 
in humans through a different mechanism of action.  
The present study was mainly focused on screening the camel whey derived 
protein hydrolysates for different bioactive properties by using three different enzymes 
and different hydrolysis time. Although, the present study’s results are valuable, 
however, they cannot be used to draw concrete conclusions on the bioactive potential 
which CWPHs might display in the in vivo systems. This is because all experiments 
were performed in vitro, and the hydrolysates may not necessarily exhibit the same 
level of bioactivity in vivo or in cellular models. Thus, validation from animal or 
human systems is critical since only in vivo studies can further elucidate on important 
factors like nature, mechanism and bioavailability and reliably assess the bioactivity 
of a given hydrolysate (FitzGerald et al., 2004; Vermeirssen et al., 2004). 
Recommendations for future work include isolation, fractionation and identification 
of bioactive peptides fragments in the hydrolysate demonstrating highest bioactive 
properties.  These studies could then pave way for incorporation of camel milk derived 
bioactive peptides in functional foods at an industrial scale along with their potential 
applications in the clinical management of chronic diseases like hypertension and 
diabetes mellitus.  
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